<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">38482000</PMID><DateCompleted><Year>2024</Year><Month>03</Month><Day>15</Day></DateCompleted><DateRevised><Year>2024</Year><Month>11</Month><Day>01</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">1664-3224</ISSN><JournalIssue CitedMedium="Internet"><Volume>15</Volume><PubDate><Year>2024</Year></PubDate></JournalIssue><Title>Frontiers in immunology</Title><ISOAbbreviation>Front Immunol</ISOAbbreviation></Journal><ArticleTitle>Pathophysiological, immunological, and inflammatory features of long COVID.</ArticleTitle><Pagination><StartPage>1341600</StartPage><MedlinePgn>1341600</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">1341600</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3389/fimmu.2024.1341600</ELocationID><Abstract><AbstractText>The COVID-19 pandemic continues to cause severe global disruption, resulting in significant excess mortality, overwhelming healthcare systems, and imposing substantial social and economic burdens on nations. While most of the attention and therapeutic efforts have concentrated on the acute phase of the disease, a notable proportion of survivors experience persistent symptoms post-infection clearance. This diverse set of symptoms, loosely categorized as long COVID, presents a potential additional public health crisis. It is estimated that 1 in 5 COVID-19 survivors exhibit clinical manifestations consistent with long COVID. Despite this prevalence, the mechanisms and pathophysiology of long COVID remain poorly understood. Alarmingly, evidence suggests that a significant proportion of cases within this clinical condition develop debilitating or disabling symptoms. Hence, urgent priority should be given to further studies on this condition to equip global public health systems for its management. This review provides an overview of available information on this emerging clinical condition, focusing on the affected individuals' epidemiology, pathophysiological mechanisms, and immunological and inflammatory profiles.</AbstractText><CopyrightInformation>Copyright &#xa9; 2024 Bohmwald, Diethelm-Varela, Rodr&#xed;guez-Guilarte, Rivera, Riedel, Gonz&#xe1;lez and Kalergis.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y" EqualContrib="Y"><LastName>Bohmwald</LastName><ForeName>Karen</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Millennium Institute on Immunology and Immunotherapy. Facultad de Ciencias Biol&#xf3;gicas, Pontificia Universidad Cat&#xf3;lica de Chile, Santiago, Chile.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Instituto de Ciencias Biom&#xe9;dicas, Facultad de Ciencias de la Salud, Universidad Aut&#xf3;noma de Chile, Santiago, Chile.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Diethelm-Varela</LastName><ForeName>Benjam&#xed;n</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Millennium Institute on Immunology and Immunotherapy. Facultad de Ciencias Biol&#xf3;gicas, Pontificia Universidad Cat&#xf3;lica de Chile, Santiago, Chile.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rodr&#xed;guez-Guilarte</LastName><ForeName>Linmar</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Millennium Institute on Immunology and Immunotherapy. Facultad de Ciencias Biol&#xf3;gicas, Pontificia Universidad Cat&#xf3;lica de Chile, Santiago, Chile.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rivera</LastName><ForeName>Thomas</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Millennium Institute on Immunology and Immunotherapy. Facultad de Ciencias Biol&#xf3;gicas, Pontificia Universidad Cat&#xf3;lica de Chile, Santiago, Chile.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Riedel</LastName><ForeName>Claudia A</ForeName><Initials>CA</Initials><AffiliationInfo><Affiliation>Millennium Institute on Immunology and Immunotherapy, Departamento de Ciencias Biol&#xf3;gicas, Facultad de Ciencias de la Vida, Universidad Andr&#xe9;s Bello, Santiago, Chile.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gonz&#xe1;lez</LastName><ForeName>Pablo A</ForeName><Initials>PA</Initials><AffiliationInfo><Affiliation>Millennium Institute on Immunology and Immunotherapy. Facultad de Ciencias Biol&#xf3;gicas, Pontificia Universidad Cat&#xf3;lica de Chile, Santiago, Chile.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kalergis</LastName><ForeName>Alexis M</ForeName><Initials>AM</Initials><AffiliationInfo><Affiliation>Millennium Institute on Immunology and Immunotherapy. Facultad de Ciencias Biol&#xf3;gicas, Pontificia Universidad Cat&#xf3;lica de Chile, Santiago, Chile.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Departamento de Endocrinolog&#xed;a, Facultad de Medicina, Pontificia Universidad Cat&#xf3;lica de Chile, Santiago, Chile.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>02</Month><Day>28</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Front Immunol</MedlineTA><NlmUniqueID>101560960</NlmUniqueID><ISSNLinking>1664-3224</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000094024" MajorTopicYN="Y">Post-Acute COVID-19 Syndrome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D058873" MajorTopicYN="N">Pandemics</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007700" MajorTopicYN="N">Kinetics</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000088562" MajorTopicYN="N">Persistent Infection</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">SARS-CoV-2</Keyword><Keyword MajorTopicYN="N">epidemiology</Keyword><Keyword MajorTopicYN="N">immune response.</Keyword><Keyword MajorTopicYN="N">long Covid</Keyword><Keyword MajorTopicYN="N">neurological alterations</Keyword><Keyword MajorTopicYN="N">pathophysiology</Keyword></KeywordList><CoiStatement>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest. The author(s) declared that they were an editorial board member of Frontiers, at the time of submission. This had no impact on the peer review process and the final decision.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>11</Month><Day>20</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>2</Month><Day>9</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>3</Month><Day>15</Day><Hour>6</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>3</Month><Day>14</Day><Hour>6</Hour><Minute>47</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>3</Month><Day>14</Day><Hour>4</Hour><Minute>17</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>1</Month><Day>1</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">38482000</ArticleId><ArticleId IdType="pmc">PMC10932978</ArticleId><ArticleId IdType="doi">10.3389/fimmu.2024.1341600</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Zhou P, Yang X-L, Wang X-G, Hu B, Zhang L, Zhang W, et al. . A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature. (2020) 579:270&#x2013;3. doi:&#xa0;10.1038/s41586-020-2012-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-020-2012-7</ArticleId><ArticleId IdType="pmc">PMC7095418</ArticleId><ArticleId IdType="pubmed">32015507</ArticleId></ArticleIdList></Reference><Reference><Citation>
Organization WH. WHO coronavirus disease (COVID-19) dashboard with vaccination data | WHO coronavirus (COVID-19) dashboard with vaccination data, in: World heal organ. (2022). Available online at: https://covid19.who.int/ (Accessed August 14, 2023).</Citation></Reference><Reference><Citation>Gold JA. Covid-19: adverse mental health outcomes for healthcare workers. BMJ. (2020) 369:m1815. doi:&#xa0;10.1136/bmj.m1815</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.m1815</ArticleId><ArticleId IdType="pubmed">32371465</ArticleId></ArticleIdList></Reference><Reference><Citation>Jones EAK, Mitra AK, Bhuiyan AR. Impact of COVID-19 on mental health in adolescents: A systematic review. Int J Environ Res Public Health. (2021) 18:2470. doi:&#xa0;10.3390/ijerph18052470</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijerph18052470</ArticleId><ArticleId IdType="pmc">PMC7967607</ArticleId><ArticleId IdType="pubmed">33802278</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee JC, Nallani R, Cass L, Bhalla V, Chiu AG, Villwock JA. A systematic review of the neuropathologic findings of post-viral olfactory dysfunction: implications and novel insight for the COVID-19 pandemic. Am J Rhinol Allergy. (2021) 35:323&#x2013;33. doi:&#xa0;10.1177/1945892420957853</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/1945892420957853</ArticleId><ArticleId IdType="pmc">PMC10404900</ArticleId><ArticleId IdType="pubmed">32915650</ArticleId></ArticleIdList></Reference><Reference><Citation>Lindert J, Jakubauskiene M, Bilsen J. The COVID-19 disaster and mental health&#x2014;assessing, responding and recovering. Eur J Public Health. (2021) 31:iv31&#x2013;5. doi:&#xa0;10.1093/eurpub/ckab153</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/eurpub/ckab153</ArticleId><ArticleId IdType="pmc">PMC8576295</ArticleId><ArticleId IdType="pubmed">34751367</ArticleId></ArticleIdList></Reference><Reference><Citation>Riedel B, Horen SR, Reynolds A, Jahromi AH. Mental health disorders in nurses during the COVID-19 pandemic: implications and coping strategies. Front Public Heal. (2021) 9:707358. doi:&#xa0;10.3389/fpubh.2021.707358</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fpubh.2021.707358</ArticleId><ArticleId IdType="pmc">PMC8575697</ArticleId><ArticleId IdType="pubmed">34765579</ArticleId></ArticleIdList></Reference><Reference><Citation>Deev O, Pl&#xed;hal T. How to calm down the markets? The effects of COVID-19 economic policy responses on financial market uncertainty. Res Int Bus Financ. (2022) 60:101613. doi:&#xa0;10.1016/j.ribaf.2022.101613</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ribaf.2022.101613</ArticleId><ArticleId IdType="pmc">PMC8750737</ArticleId><ArticleId IdType="pubmed">35035020</ArticleId></ArticleIdList></Reference><Reference><Citation>Drieskens S, Braekman E, De Ridder K, Gisle L, Charafeddine R, Hermans L, et al. . Domestic violence during the COVID-19 confinement: do victims feel more socially isolated? Arch Public Heal. (2022) 80:39. doi:&#xa0;10.1186/s13690-021-00765-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13690-021-00765-3</ArticleId><ArticleId IdType="pmc">PMC8787181</ArticleId><ArticleId IdType="pubmed">35078519</ArticleId></ArticleIdList></Reference><Reference><Citation>Kondo MC, Felker-Kantor E, Wu K, Gustat J, Morrison CN, Richardson L, et al. . Stress and distress during the COVID-19 pandemic: the role of neighborhood context. Int J Environ Res Public Health. (2022) 19:2779. doi:&#xa0;10.3390/ijerph19052779</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijerph19052779</ArticleId><ArticleId IdType="pmc">PMC8910081</ArticleId><ArticleId IdType="pubmed">35270488</ArticleId></ArticleIdList></Reference><Reference><Citation>Richards F, Kodjamanova P, Chen X, Li N, Atanasov P, Bennetts L, et al. . Economic burden of COVID-19: A systematic review. Clin Outcomes Res. (2022) 14:293&#x2013;307. doi:&#xa0;10.2147/CEOR.S338225</Citation><ArticleIdList><ArticleId IdType="doi">10.2147/CEOR.S338225</ArticleId><ArticleId IdType="pmc">PMC9060810</ArticleId><ArticleId IdType="pubmed">35509962</ArticleId></ArticleIdList></Reference><Reference><Citation>
for Disease Control C, Prevention . Long COVID or post-COVID conditions (2022). Available online at: https://www.cdc.gov/coronavirus/2019-ncov/long-term-effects/index.html.</Citation></Reference><Reference><Citation>
for Disease Control C, Prevention . Post-COVID conditions: information for healthcare providers (2021). Available online at: https://www.cdc.gov/coronavirus/2019-ncov/hcp/clinical-care/post-covid-conditions.html?CDC_AA_refVal=https%3A%2F%2Fwww.cdc.gov%2Fcoronavirus%2F2019-ncov%2Fhcp%2Fclinical-care%2Flate-sequelae.html.</Citation></Reference><Reference><Citation>Krishna B, Wills M, Sithole N. Long COVID: what is known and what gaps need to be addressed. Br Med Bull. (2023) 147:6&#x2013;19. doi:&#xa0;10.1093/BMB/LDAD016</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/BMB/LDAD016</ArticleId><ArticleId IdType="pmc">PMC10502447</ArticleId><ArticleId IdType="pubmed">37434326</ArticleId></ArticleIdList></Reference><Reference><Citation>Sasannejad C, Ely EW, Lahiri S. Long-term cognitive impairment after acute respiratory distress syndrome: a review of clinical impact and pathophysiological mechanisms. Crit Care. (2019) 23:352. doi:&#xa0;10.1186/s13054-019-2626-z</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13054-019-2626-z</ArticleId><ArticleId IdType="pmc">PMC6852966</ArticleId><ArticleId IdType="pubmed">31718695</ArticleId></ArticleIdList></Reference><Reference><Citation>Tansey CM. One-year outcomes and health care utilization in survivors of severe acute respiratory syndrome. Arch Intern Med. (2007) 167:1312. doi:&#xa0;10.1001/archinte.167.12.1312</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/archinte.167.12.1312</ArticleId><ArticleId IdType="pubmed">17592106</ArticleId></ArticleIdList></Reference><Reference><Citation>Ali ST, Kang AK, Patel TR, Clark JR, Perez-Giraldo GS, Orban ZS, et al. . Evolution of neurologic symptoms in non-hospitalized COVID-19 &#x201c;long haulers&#x201d;. Ann Clin Transl Neurol. (2022) 9(7):950&#x2013;61. doi:&#xa0;10.1002/acn3.51570</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/acn3.51570</ArticleId><ArticleId IdType="pmc">PMC9268866</ArticleId><ArticleId IdType="pubmed">35607826</ArticleId></ArticleIdList></Reference><Reference><Citation>Belli S, Balbi B, Prince I, Cattaneo D, Masocco F, Zaccaria S, et al. . Low physical functioning and impaired performance of activities of daily life in COVID-19 patients who survived hospitalisation. Eur Respir J. (2020) 56:2002096. doi:&#xa0;10.1183/13993003.02096-2020</Citation><ArticleIdList><ArticleId IdType="doi">10.1183/13993003.02096-2020</ArticleId><ArticleId IdType="pmc">PMC7411272</ArticleId><ArticleId IdType="pubmed">32764112</ArticleId></ArticleIdList></Reference><Reference><Citation>Blomberg B, Mohn KG-I, Brokstad KA, Zhou F, Linchausen DW, Hansen B-A, et al. . Long COVID in a prospective cohort of home-isolated patients. Nat Med. (2021) 27:1607&#x2013;13. doi:&#xa0;10.1038/s41591-021-01433-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-021-01433-3</ArticleId><ArticleId IdType="pmc">PMC8440190</ArticleId><ArticleId IdType="pubmed">34163090</ArticleId></ArticleIdList></Reference><Reference><Citation>Bull-Otterson L, Baca S, Saydah S, Boehmer TK, Adjei S, Gray S, et al. . Post&#x2013;COVID conditions among adult COVID-19 survivors aged 18&#x2013;64 and &#x2265;65 years &#x2014; United states, march 2020&#x2013;november 2021. MMWR Morb Mortal Wkly Rep. (2022) 71:713&#x2013;7. doi:&#xa0;10.15585/mmwr.mm7121e1</Citation><ArticleIdList><ArticleId IdType="doi">10.15585/mmwr.mm7121e1</ArticleId></ArticleIdList></Reference><Reference><Citation>Moreno-P&#xe9;rez O, Merino E, Leon-Ramirez J-M, Andres M, Ramos JM, Arenas-Jim&#xe9;nez J, et al. . Post-acute COVID-19 syndrome. Incidence and risk factors: A Mediterranean cohort study. J Infect. (2021) 82:378&#x2013;83. doi:&#xa0;10.1016/j.jinf.2021.01.004</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jinf.2021.01.004</ArticleId><ArticleId IdType="pmc">PMC7802523</ArticleId><ArticleId IdType="pubmed">33450302</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen C, Haupert SR, Zimmermann L, Shi X, Fritsche LG, Mukherjee B. Global prevalence of post COVID-19 condition or long COVID: A meta-analysis and systematic review. J Infect Dis. (2022) 226(9):1593&#x2013;607. doi:&#xa0;10.1093/infdis/jiac136</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/infdis/jiac136</ArticleId><ArticleId IdType="pmc">PMC9047189</ArticleId><ArticleId IdType="pubmed">35429399</ArticleId></ArticleIdList></Reference><Reference><Citation>Peluso MJ, Deitchman AN, Torres L, Iyer NS, Munter SE, Nixon CC, et al. . Long-term SARS-CoV-2-specific immune and inflammatory responses in individuals recovering from COVID-19 with and without post-acute symptoms. Cell Rep. (2021) 36:109518. doi:&#xa0;10.1016/j.celrep.2021.109518</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.celrep.2021.109518</ArticleId><ArticleId IdType="pmc">PMC8342976</ArticleId><ArticleId IdType="pubmed">34358460</ArticleId></ArticleIdList></Reference><Reference><Citation>Frontera JA, Yang D, Lewis A, Patel P, Medicherla C, Arena V, et al. . A prospective study of long-term outcomes among hospitalized COVID-19 patients with and without neurological complications. J Neurol Sci. (2021) 426:117486. doi:&#xa0;10.1016/j.jns.2021.117486</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jns.2021.117486</ArticleId><ArticleId IdType="pmc">PMC8113108</ArticleId><ArticleId IdType="pubmed">34000678</ArticleId></ArticleIdList></Reference><Reference><Citation>Sigfrid L, Drake TM, Pauley E, Jesudason EC, Olliaro P, Lim WS, et al. . Long Covid in adults discharged from UK hospitals after Covid-19: A prospective, multicentre cohort study using the ISARIC WHO Clinical Characterisation Protocol. Lancet Reg Heal - Eur. (2021) 8:100186. doi:&#xa0;10.1016/j.lanepe.2021.100186</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.lanepe.2021.100186</ArticleId><ArticleId IdType="pmc">PMC8343377</ArticleId><ArticleId IdType="pubmed">34386785</ArticleId></ArticleIdList></Reference><Reference><Citation>Carf&#xec; A, Bernabei R, Landi F. Persistent symptoms in patients after acute COVID-19. JAMA. (2020) 324:603. doi:&#xa0;10.1001/jama.2020.12603</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2020.12603</ArticleId><ArticleId IdType="pmc">PMC7349096</ArticleId><ArticleId IdType="pubmed">32644129</ArticleId></ArticleIdList></Reference><Reference><Citation>Raveendran AV, Jayadevan R, Sashidharan S. Long COVID: an overview. Diabetes Metab Syndr Clin Res Rev. (2021) 15:869&#x2013;75. doi:&#xa0;10.1016/j.dsx.2021.04.007</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.dsx.2021.04.007</ArticleId><ArticleId IdType="pmc">PMC9637465</ArticleId><ArticleId IdType="pubmed">36351871</ArticleId></ArticleIdList></Reference><Reference><Citation>Tenforde MW, Kim SS, Lindsell CJ, Rose EB, Shapiro NI, Files DC, et al. . Symptom duration and risk factors for delayed return to usual health among outpatients with COVID-19 in a multistate health care systems network &#x2014; United states, march&#x2013;june 2020. MMWR Morb Mortal Wkly Rep. (2020) 69:993&#x2013;8. doi:&#xa0;10.15585/mmwr.mm6930e1</Citation><ArticleIdList><ArticleId IdType="doi">10.15585/mmwr.mm6930e1</ArticleId><ArticleId IdType="pmc">PMC7392393</ArticleId><ArticleId IdType="pubmed">32730238</ArticleId></ArticleIdList></Reference><Reference><Citation>Rasa S, Nora-Krukle Z, Henning N, Eliassen E, Shikova E, Harrer T, et al. . Chronic viral infections in myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS). J Transl Med. (2018) 16:268. doi:&#xa0;10.1186/s12967-018-1644-y</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12967-018-1644-y</ArticleId><ArticleId IdType="pmc">PMC6167797</ArticleId><ArticleId IdType="pubmed">30285773</ArticleId></ArticleIdList></Reference><Reference><Citation>Antonelli M, Pujol JC, Spector TD, Ourselin S, Steves CJ. Risk of long COVID associated with delta versus omicron variants of SARS-CoV-2. Lancet (London England). (2022) 399:2263&#x2013;4. doi:&#xa0;10.1016/S0140-6736(22)00941-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(22)00941-2</ArticleId><ArticleId IdType="pmc">PMC9212672</ArticleId><ArticleId IdType="pubmed">35717982</ArticleId></ArticleIdList></Reference><Reference><Citation>Cai J, Lin K, Zhang H, Xue Q, Zhu K, Yuan G, et al. . A one-year follow-up study of systematic impact of long COVID symptoms among patients post SARS-CoV-2 omicron variants infection in Shanghai, China. Emerg Microbes Infect. (2023) 12:2220578. doi:&#xa0;10.1080/22221751.2023.2220578</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/22221751.2023.2220578</ArticleId><ArticleId IdType="pmc">PMC10281439</ArticleId><ArticleId IdType="pubmed">37272336</ArticleId></ArticleIdList></Reference><Reference><Citation>Graham EL, Clark JR, Orban ZS, Lim PH, Szymanski AL, Taylor C, et al. . Persistent neurologic symptoms and cognitive dysfunction in non-hospitalized Covid-19 &#x201c;long haulers&#x201d;. Ann Clin Transl Neurol. (2021) 8:1073&#x2013;85. doi:&#xa0;10.1002/acn3.51350</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/acn3.51350</ArticleId><ArticleId IdType="pmc">PMC8108421</ArticleId><ArticleId IdType="pubmed">33755344</ArticleId></ArticleIdList></Reference><Reference><Citation>Abdelwahab N, Ingraham NE, Nguyen N, Siegel L, Silverman G, Sahoo HS, et al. . Predictors of post-acute sequelae of COVID-19 development and rehabilitation: A retrospective study. Arch Phys Med Rehabil. (2022) 103:2001. doi:&#xa0;10.1016/j.apmr.2022.04.009</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.apmr.2022.04.009</ArticleId><ArticleId IdType="pmc">PMC9098397</ArticleId><ArticleId IdType="pubmed">35569640</ArticleId></ArticleIdList></Reference><Reference><Citation>Atchison CJ, Davies B, Cooper E, Lound A, Whitaker M, Hampshire A, et al. . Long-term health impacts of COVID-19 among 242,712 adults in England. Nat Commun. (2023) 14:6588. doi:&#xa0;10.1038/S41467-023-41879-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/S41467-023-41879-2</ArticleId><ArticleId IdType="pmc">PMC10598213</ArticleId><ArticleId IdType="pubmed">37875536</ArticleId></ArticleIdList></Reference><Reference><Citation>Romero-Ibarguengoitia ME, Rodr&#xed;guez-Torres JF, Garza-Silva A, Rivera-Cavazos A, Morales-Rodriguez DP, Hurtado-Cabrera M, et al. . Association of vaccine status, reinfections, and risk factors with Long COVID syndrome. Sci Rep. (2024) 14:2817. doi:&#xa0;10.1038/S41598-024-52925-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/S41598-024-52925-4</ArticleId><ArticleId IdType="pmc">PMC10837423</ArticleId><ArticleId IdType="pubmed">38307886</ArticleId></ArticleIdList></Reference><Reference><Citation>Pazukhina E, Rumyantsev M, Baimukhambetova D, Bondarenko E, Markina N, El-Taravi Y, et al. . Event rates and incidence of post-COVID-19 condition in hospitalised SARS-CoV-2 positive children and young people and controls across different pandemic waves: exposure-stratified prospective cohort study in Moscow (StopCOVID). BMC Med. (2024) 22:48. doi:&#xa0;10.1186/S12916-023-03221-X</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/S12916-023-03221-X</ArticleId><ArticleId IdType="pmc">PMC10835884</ArticleId><ArticleId IdType="pubmed">38302974</ArticleId></ArticleIdList></Reference><Reference><Citation>Bigdelou B, Sepand MR, Najafikhoshnoo S, Negrete JAT, Sharaf M, Ho JQ, et al. . COVID-19 and preexisting comorbidities: risks, synergies, and clinical outcomes. Front Immunol. (2022) 13:890517. doi:&#xa0;10.3389/fimmu.2022.890517</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2022.890517</ArticleId><ArticleId IdType="pmc">PMC9196863</ArticleId><ArticleId IdType="pubmed">35711466</ArticleId></ArticleIdList></Reference><Reference><Citation>Hussain A, Bhowmik B, do Vale Moreira NC. COVID-19 and diabetes: Knowledge in progress. Diabetes Res Clin Pract. (2020) 162:108142. doi:&#xa0;10.1016/j.diabres.2020.108142</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.diabres.2020.108142</ArticleId><ArticleId IdType="pmc">PMC7144611</ArticleId><ArticleId IdType="pubmed">32278764</ArticleId></ArticleIdList></Reference><Reference><Citation>Lima-Mart&#xed;nez MM, Boada CC, Madera-Silva MD, Mar&#xed;n W, Contreras M. COVID-19 y diabetes mellitus: una relaci&#xf3;n bidireccional. Cl&#xed;nica e Investig en Arterioscler. (2021) 33:151&#x2013;7. doi:&#xa0;10.1016/j.arteri.2020.10.001</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.arteri.2020.10.001</ArticleId><ArticleId IdType="pmc">PMC7598432</ArticleId><ArticleId IdType="pubmed">33303218</ArticleId></ArticleIdList></Reference><Reference><Citation>Su Y, Yuan D, Chen DG, Ng RH, Wang K, Choi J, et al. . Multiple early factors anticipate post-acute COVID-19 sequelae. Cell. (2022) 185:881&#x2013;895.e20. doi:&#xa0;10.1016/j.cell.2022.01.014</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2022.01.014</ArticleId><ArticleId IdType="pmc">PMC8786632</ArticleId><ArticleId IdType="pubmed">35216672</ArticleId></ArticleIdList></Reference><Reference><Citation>Tleyjeh IM, Kashour T, Riaz M, Amer SA, AlSwaidan N, Almutairi L, et al. . Persistent COVID-19 symptoms at least one month after diagnosis: A national survey. J Infect Public Health. (2022) 15:578&#x2013;85. doi:&#xa0;10.1016/j.jiph.2022.04.006</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jiph.2022.04.006</ArticleId><ArticleId IdType="pmc">PMC9020835</ArticleId><ArticleId IdType="pubmed">35477145</ArticleId></ArticleIdList></Reference><Reference><Citation>Yong SJ. Long COVID or post-COVID-19 syndrome: putative pathophysiology, risk factors, and treatments. Infect Dis (Auckl). (2021) 53:737&#x2013;54. doi:&#xa0;10.1080/23744235.2021.1924397</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/23744235.2021.1924397</ArticleId><ArticleId IdType="pmc">PMC8146298</ArticleId><ArticleId IdType="pubmed">34024217</ArticleId></ArticleIdList></Reference><Reference><Citation>Booth A, Reed AB, Ponzo S, Yassaee A, Aral M, Plans D, et al. . Population risk factors for severe disease and mortality in COVID-19: A global systematic review and meta-analysis. PloS One. (2021) 16:e0247461. doi:&#xa0;10.1371/journal.pone.0247461</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0247461</ArticleId><ArticleId IdType="pmc">PMC7932512</ArticleId><ArticleId IdType="pubmed">33661992</ArticleId></ArticleIdList></Reference><Reference><Citation>Ruan Q, Yang K, Wang W, Jiang L, Song J. Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan, China. Intensive Care Med. (2020) 46:846&#x2013;8. doi:&#xa0;10.1007/s00134-020-05991-x</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00134-020-05991-x</ArticleId><ArticleId IdType="pmc">PMC7080116</ArticleId><ArticleId IdType="pubmed">32125452</ArticleId></ArticleIdList></Reference><Reference><Citation>Kamal M, Omirah MA, Hussein A, Saeed H. Assessment and characterisation of post-COVID-19 manifestations. Int J Clin Pract. (2021) 75:e13746. doi:&#xa0;10.1111/ijcp.13746</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/ijcp.13746</ArticleId><ArticleId IdType="pmc">PMC7536922</ArticleId><ArticleId IdType="pubmed">32991035</ArticleId></ArticleIdList></Reference><Reference><Citation>Stavem K, Ghanima W, Olsen MK, Gilboe HM, Einvik G. Persistent symptoms 1.5&#x2013;6 months after COVID-19 in non-hospitalised subjects: a population-based cohort study. Thorax. (2021) 76:405&#x2013;7. doi:&#xa0;10.1136/thoraxjnl-2020-216377</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/thoraxjnl-2020-216377</ArticleId><ArticleId IdType="pmc">PMC7716295</ArticleId><ArticleId IdType="pubmed">33273028</ArticleId></ArticleIdList></Reference><Reference><Citation>Xie Y, Bowe B, Al-Aly Z. Burdens of post-acute sequelae of COVID-19 by severity of acute infection, demographics and health status. Nat Commun. (2021) 12:6571. doi:&#xa0;10.1038/s41467-021-26513-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-021-26513-3</ArticleId><ArticleId IdType="pmc">PMC8589966</ArticleId><ArticleId IdType="pubmed">34772922</ArticleId></ArticleIdList></Reference><Reference><Citation>Douaud G, Lee S, Alfaro-Almagro F, Arthofer C, Wang C, McCarthy P, et al. . SARS-CoV-2 is associated with changes in brain structure in UK Biobank. Nature. (2022) 604:697&#x2013;707. doi:&#xa0;10.1038/s41586-022-04569-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-022-04569-5</ArticleId><ArticleId IdType="pmc">PMC9046077</ArticleId><ArticleId IdType="pubmed">35255491</ArticleId></ArticleIdList></Reference><Reference><Citation>Jozuka R, Kimura H, Uematsu T, Fujigaki H, Yamamoto Y, Kobayashi M, et al. . Severe and long-lasting neuropsychiatric symptoms after mild respiratory symptoms caused by COVID-19: A case report. Neuropsychopharmacol Rep. (2022) 42:114&#x2013;9. doi:&#xa0;10.1002/npr2.12222</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/npr2.12222</ArticleId><ArticleId IdType="pmc">PMC8919122</ArticleId><ArticleId IdType="pubmed">34889531</ArticleId></ArticleIdList></Reference><Reference><Citation>Rusk N. The UK biobank. Nat Methods. (2018) 15:1001. doi:&#xa0;10.1038/s41592-018-0245-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41592-018-0245-2</ArticleId><ArticleId IdType="pubmed">30504882</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, et al. . Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. (2020) 395:497&#x2013;506. doi:&#xa0;10.1016/S0140-6736(20)30183-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(20)30183-5</ArticleId><ArticleId IdType="pmc">PMC7159299</ArticleId><ArticleId IdType="pubmed">31986264</ArticleId></ArticleIdList></Reference><Reference><Citation>O&#x2019;Mahoney LL, Routen A, Gillies C, Ekezie W, Welford A, Zhang A, et al. . The prevalence and long-term health effects of Long Covid among hospitalised and non-hospitalised populations: A systematic review and meta-analysis. eClinicalMedicine. (2023) 55:101762. doi:&#xa0;10.1016/j.eclinm.2022.101762</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.eclinm.2022.101762</ArticleId><ArticleId IdType="pmc">PMC9714474</ArticleId><ArticleId IdType="pubmed">36474804</ArticleId></ArticleIdList></Reference><Reference><Citation>Abarca K, Iturriaga C, Urz&#xfa;a M, Le Corre N, Pineda A, Fern&#xe1;ndez C, et al. . Safety and non-inferiority evaluation of two immunization schedules with an inactivated SARS-coV-2 vaccine in adults: A randomized clinical trial. Vaccines. (2022) 10:1082. doi:&#xa0;10.3390/vaccines10071082</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/vaccines10071082</ArticleId><ArticleId IdType="pmc">PMC9323976</ArticleId><ArticleId IdType="pubmed">35891246</ArticleId></ArticleIdList></Reference><Reference><Citation>Ghosn J, Piroth L, Epaulard O, Le Turnier P, Mentr&#xe9; F, Bachelet D, et al. . Persistent COVID-19 symptoms are highly prevalent 6 months after hospitalization: results from a large prospective cohort. Clin Microbiol Infect. (2021) 27:1041.e1&#x2013;1041.e4. doi:&#xa0;10.1016/J.CMI.2021.03.012</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/J.CMI.2021.03.012</ArticleId><ArticleId IdType="pmc">PMC8107834</ArticleId><ArticleId IdType="pubmed">34125067</ArticleId></ArticleIdList></Reference><Reference><Citation>Peghin M, Palese A, Venturini M, De Martino M, Gerussi V, Graziano E, et al. . Post-COVID-19 symptoms 6 months after acute infection among hospitalized and non-hospitalized patients. Clin Microbiol Infect. (2021) 27:1507&#x2013;13. doi:&#xa0;10.1016/J.CMI.2021.05.033</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/J.CMI.2021.05.033</ArticleId><ArticleId IdType="pmc">PMC8180450</ArticleId><ArticleId IdType="pubmed">34111579</ArticleId></ArticleIdList></Reference><Reference><Citation>Sykes DL, Holdsworth L, Jawad N, Gunasekera P, Morice AH, Crooks MG. Post-COVID-19 symptom burden: what is long-COVID and how should we manage it? Lung. (2021) 199:113&#x2013;9. doi:&#xa0;10.1007/s00408-021-00423-z</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00408-021-00423-z</ArticleId><ArticleId IdType="pmc">PMC7875681</ArticleId><ArticleId IdType="pubmed">33569660</ArticleId></ArticleIdList></Reference><Reference><Citation>Xiong Q, Xu M, Li J, Liu Y, Zhang J, Xu Y, et al. . Clinical sequelae of COVID-19 survivors in Wuhan, China: a single-centre longitudinal study. Clin Microbiol Infect. (2021) 27:89. doi:&#xa0;10.1016/J.CMI.2020.09.023</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/J.CMI.2020.09.023</ArticleId><ArticleId IdType="pmc">PMC7510771</ArticleId><ArticleId IdType="pubmed">32979574</ArticleId></ArticleIdList></Reference><Reference><Citation>Fern&#xe1;ndez-De-las-pe&#xf1;as C, Mart&#xed;n-Guerrero JD, Pellicer-Valero &#xd3;J, Navarro-Pardo E, G&#xf3;mez-Mayordomo V, Cuadrado ML, et al. . Female sex is a risk factor associated with long-term post-COVID related-symptoms but not with COVID-19 symptoms: the LONG-COVID-EXP-CM multicenter study. J Clin Med. (2022) 11:413. doi:&#xa0;10.3390/JCM11020413</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/JCM11020413</ArticleId><ArticleId IdType="pmc">PMC8778106</ArticleId><ArticleId IdType="pubmed">35054108</ArticleId></ArticleIdList></Reference><Reference><Citation>Bai F, Tomasoni D, Falcinella C, Barbanotti D, Castoldi R, Mul&#xe8; G, et al. . Female gender is associated with long COVID syndrome: a prospective cohort study. Clin Microbiol Infect. (2022) 28:611.e9&#x2013;611.e16. doi:&#xa0;10.1016/J.CMI.2021.11.002</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/J.CMI.2021.11.002</ArticleId><ArticleId IdType="pmc">PMC8575536</ArticleId><ArticleId IdType="pubmed">34763058</ArticleId></ArticleIdList></Reference><Reference><Citation>Bwire GM. Coronavirus: why men are more vulnerable to covid-19 than women? SN Compr Clin Med. (2020) 2:874&#x2013;6. doi:&#xa0;10.1007/s42399-020-00341-w</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s42399-020-00341-w</ArticleId><ArticleId IdType="pmc">PMC7271824</ArticleId><ArticleId IdType="pubmed">32838138</ArticleId></ArticleIdList></Reference><Reference><Citation>Klein SL, Flanagan KL. Sex differences in immune responses. Nat Rev Immunol. (2016) 16:626&#x2013;38. doi:&#xa0;10.1038/nri.2016.90</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nri.2016.90</ArticleId><ArticleId IdType="pubmed">27546235</ArticleId></ArticleIdList></Reference><Reference><Citation>Lu J, Peng J, Xiong Q, Liu Z, Lin H, Tan X, et al. . Clinical, immunological and virological characterization of COVID-19 patients that test re-positive for SARS-CoV-2 by RT-PCR. eBioMedicine. (2020) 59:102960. doi:&#xa0;10.1016/j.ebiom.2020.102960</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ebiom.2020.102960</ArticleId><ArticleId IdType="pmc">PMC7444471</ArticleId><ArticleId IdType="pubmed">32853988</ArticleId></ArticleIdList></Reference><Reference><Citation>Rhee C, Kanjilal S, Baker M, Klompas M. Duration of severe acute respiratory syndrome coronavirus 2 (SARS-coV-2) infectivity: when is it safe to discontinue isolation? Clin Infect Dis. (2021) 72:1467&#x2013;74. doi:&#xa0;10.1093/cid/ciaa1249</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cid/ciaa1249</ArticleId><ArticleId IdType="pmc">PMC7499497</ArticleId><ArticleId IdType="pubmed">33029620</ArticleId></ArticleIdList></Reference><Reference><Citation>O&#x2019;Donnell JS, Chappell KJ. Chronic SARS-coV-2, a cause of post-acute COVID-19 sequelae (Long-COVID)? Front Microbiol. (2021) 12:724654. doi:&#xa0;10.3389/fmicb.2021.724654</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmicb.2021.724654</ArticleId><ArticleId IdType="pmc">PMC8365243</ArticleId><ArticleId IdType="pubmed">34408742</ArticleId></ArticleIdList></Reference><Reference><Citation>Swank Z, Senussi Y, Manickas-Hill Z, Yu XG, Li JZ, Alter G, et al. . Persistent circulating severe acute respiratory syndrome coronavirus 2 spike is associated with post-acute coronavirus disease 2019 sequelae. Clin Infect Dis. (2023) 76:e487&#x2013;90. doi:&#xa0;10.1093/CID/CIAC722</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/CID/CIAC722</ArticleId><ArticleId IdType="pmc">PMC10169416</ArticleId><ArticleId IdType="pubmed">36052466</ArticleId></ArticleIdList></Reference><Reference><Citation>Callaway E. How months-long COVID infections could seed dangerous new variants. Nature. (2022) 606:452&#x2013;5. doi:&#xa0;10.1038/d41586-022-01613-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/d41586-022-01613-2</ArticleId><ArticleId IdType="pubmed">35705825</ArticleId></ArticleIdList></Reference><Reference><Citation>Theoharides TC. Could SARS-coV-2 spike protein be responsible for long-COVID syndrome? Mol Neurobiol. (2022) 59:1850&#x2013;61. doi:&#xa0;10.1007/s12035-021-02696-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12035-021-02696-0</ArticleId><ArticleId IdType="pmc">PMC8757925</ArticleId><ArticleId IdType="pubmed">35028901</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu X, Xiang M, Jing H, Wang C, Novakovic VA, Shi J. Damage to endothelial barriers and its contribution to long COVID. Angiogenesis. (2023) 27:1&#x2013;8. doi:&#xa0;10.1007/S10456-023-09878-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/S10456-023-09878-5</ArticleId><ArticleId IdType="pmc">PMC10134732</ArticleId><ArticleId IdType="pubmed">37103631</ArticleId></ArticleIdList></Reference><Reference><Citation>Kemp SA, Collier DA, Datir RP, Ferreira IATM, Gayed S, Jahun A, et al. . SARS-CoV-2 evolution during treatment of chronic infection. Nature. (2021) 592:277&#x2013;82. doi:&#xa0;10.1038/s41586-021-03291-y</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-021-03291-y</ArticleId><ArticleId IdType="pmc">PMC7610568</ArticleId><ArticleId IdType="pubmed">33545711</ArticleId></ArticleIdList></Reference><Reference><Citation>Choi B, Choudhary MC, Regan J, Sparks JA, Padera RF, Qiu X, et al. . Persistence and evolution of SARS-coV-2 in an immunocompromised host. N Engl J Med. (2020) 383:2291&#x2013;3. doi:&#xa0;10.1056/NEJMc2031364</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMc2031364</ArticleId><ArticleId IdType="pmc">PMC7673303</ArticleId><ArticleId IdType="pubmed">33176080</ArticleId></ArticleIdList></Reference><Reference><Citation>Sonnleitner ST, Prelog M, Sonnleitner S, Hinterbichler E, Halbfurter H, Kopecky DBC, et al. . Cumulative SARS-CoV-2 mutations and corresponding changes in immunity in an immunocompromised patient indicate viral evolution within the host. Nat Commun. (2022) 13:2560. doi:&#xa0;10.1038/s41467-022-30163-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-022-30163-4</ArticleId><ArticleId IdType="pmc">PMC9090742</ArticleId><ArticleId IdType="pubmed">35538074</ArticleId></ArticleIdList></Reference><Reference><Citation>Tian F, Tong B, Sun L, Shi S, Zheng B, Wang Z, et al. . N501Y mutation of spike protein in SARS-CoV-2 strengthens its binding to receptor ACE2. Elife. (2021) 10:e69091. doi:&#xa0;10.7554/eLife.69091</Citation><ArticleIdList><ArticleId IdType="doi">10.7554/eLife.69091</ArticleId><ArticleId IdType="pmc">PMC8455130</ArticleId><ArticleId IdType="pubmed">34414884</ArticleId></ArticleIdList></Reference><Reference><Citation>Bradley RE, Ponsford MJ, Scurr MJ, Godkin A, Jolles S, Bramhall K, et al. . Persistent COVID-19 infection in wiskott-aldrich syndrome cleared following therapeutic vaccination: a case report. J Clin Immunol. (2022) 42:32&#x2013;5. doi:&#xa0;10.1007/s10875-021-01158-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10875-021-01158-5</ArticleId><ArticleId IdType="pmc">PMC8554737</ArticleId><ArticleId IdType="pubmed">34714497</ArticleId></ArticleIdList></Reference><Reference><Citation>Al-Aly Z, Bowe B, Xie Y. Long COVID after breakthrough SARS-CoV-2 infection. Nat Med. (2022) 28:1461&#x2013;7. doi:&#xa0;10.1038/s41591-022-01840-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-022-01840-0</ArticleId><ArticleId IdType="pmc">PMC9307472</ArticleId><ArticleId IdType="pubmed">35614233</ArticleId></ArticleIdList></Reference><Reference><Citation>Gaete-Argel A, Saavedra-Alarc&#xf3;n V, Saur&#xe9; D, Alonso-Palomares L, Acevedo ML, Alarc&#xf3;n M, et al. . Impact of homologous and heterologous boosters in neutralizing antibodies titers against SARS-CoV-2 Omicron in solid-organ transplant recipients. Front Immunol. (2023) 14:1135478. doi:&#xa0;10.3389/FIMMU.2023.1135478</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/FIMMU.2023.1135478</ArticleId><ArticleId IdType="pmc">PMC10044136</ArticleId><ArticleId IdType="pubmed">36999018</ArticleId></ArticleIdList></Reference><Reference><Citation>Soto JA, Melo-Gonz&#xe1;lez F, Gutierrez-Vera C, Schultz BM, Berr&#xed;os-Rojas RV, Rivera-P&#xe9;rez D, et al. . Inactivated vaccine-induced SARS-coV-2 variant-specific immunity in children. MBio. (2022) 13:e0131122. doi:&#xa0;10.1128/MBIO.01311-22</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/MBIO.01311-22</ArticleId><ArticleId IdType="pmc">PMC9765711</ArticleId><ArticleId IdType="pubmed">36383021</ArticleId></ArticleIdList></Reference><Reference><Citation>Mondaca S, Walbaum B, Le Corre N, Ferr&#xe9;s M, Vald&#xe9;s A, Mart&#xed;nez-Valdebenito C, et al. . Influence of SARS-CoV-2 mRNA Vaccine Booster among Cancer Patients on Active Treatment Previously Immunized with Inactivated versus mRNA Vaccines: A Prospective Cohort Study. Vaccines. (2023) 11:1193. doi:&#xa0;10.3390/VACCINES11071193</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/VACCINES11071193</ArticleId><ArticleId IdType="pmc">PMC10384024</ArticleId><ArticleId IdType="pubmed">37515009</ArticleId></ArticleIdList></Reference><Reference><Citation>Melo-Gonz&#xe1;lez F, Soto JA, Gonz&#xe1;lez LA, Fern&#xe1;ndez J, Duarte LF, Schultz BM, et al. . Recognition of variants of concern by antibodies and T cells induced by a SARS-coV-2 inactivated vaccine. Front Immunol. (2021) 12:747830. doi:&#xa0;10.3389/fimmu.2021.747830</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2021.747830</ArticleId><ArticleId IdType="pmc">PMC8630786</ArticleId><ArticleId IdType="pubmed">34858404</ArticleId></ArticleIdList></Reference><Reference><Citation>Balcells ME, Le Corre N, Dur&#xe1;n J, Ceballos ME, Vizcaya C, Mondaca S, et al. . Reduced immune response to inactivated severe acute respiratory syndrome coronavirus 2 vaccine in a cohort of immunocompromised patients in Chile. Clin Infect Dis. (2022) 75:e594&#x2013;602. doi:&#xa0;10.1093/cid/ciac167</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cid/ciac167</ArticleId><ArticleId IdType="pmc">PMC8903589</ArticleId><ArticleId IdType="pubmed">35255140</ArticleId></ArticleIdList></Reference><Reference><Citation>Bueno SM, Abarca K, Gonz&#xe1;lez PA, G&#xe1;lvez NMSS, Soto JA, Duarte LF, et al. . Safety and immunogenicity of an inactivated severe acute respiratory syndrome coronavirus 2 vaccine in a subgroup of healthy adults in Chile. Clin Infect Dis. (2021) 75:E792&#x2013;804. doi:&#xa0;10.1093/cid/ciab823</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cid/ciab823</ArticleId><ArticleId IdType="pmc">PMC9402626</ArticleId><ArticleId IdType="pubmed">34537835</ArticleId></ArticleIdList></Reference><Reference><Citation>Dib M, Le Corre N, Ortiz C, Garc&#xed;a D, Ferr&#xe9;s M, Martinez-Valdebenito C, et al. . SARS-CoV-2 vaccine booster in solid organ transplant recipients previously immunised with inactivated versus mRNA vaccines: A prospective cohort study. Lancet Reg Heal - Am. (2022) 16:100371. doi:&#xa0;10.1016/j.lana.2022.100371</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.lana.2022.100371</ArticleId><ArticleId IdType="pmc">PMC9503242</ArticleId><ArticleId IdType="pubmed">36185969</ArticleId></ArticleIdList></Reference><Reference><Citation>Harrison S, Walters B, Simmons Z, Cook M, Clark R. The effectiveness of vaccination against long COVID. A Rapid evidence briefing. (2022).</Citation></Reference><Reference><Citation>Ledford H. Do vaccines protect against long COVID? What the data say. Nature. (2021) 599:546&#x2013;8. doi:&#xa0;10.1038/d41586-021-03495-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/d41586-021-03495-2</ArticleId><ArticleId IdType="pubmed">34815580</ArticleId></ArticleIdList></Reference><Reference><Citation>Strain WD, Sherwood O, Banerjee A, Van der Togt V, Hishmeh L, Rossman J. The impact of COVID vaccination on symptoms of long COVID: an international survey of people with lived experience of long COVID. Vaccines. (2022) 10:652. doi:&#xa0;10.3390/vaccines10050652</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/vaccines10050652</ArticleId><ArticleId IdType="pmc">PMC9146071</ArticleId><ArticleId IdType="pubmed">35632408</ArticleId></ArticleIdList></Reference><Reference><Citation>Duarte LF, G&#xe1;lvez NMS, Iturriaga C, Melo-Gonz&#xe1;lez F, Soto JA, Schultz BM, et al. . Immune profile and clinical outcome of breakthrough cases after vaccination with an inactivated SARS-coV-2 vaccine. Front Immunol. (2021) 12:742914. doi:&#xa0;10.3389/fimmu.2021.742914</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2021.742914</ArticleId><ArticleId IdType="pmc">PMC8511644</ArticleId><ArticleId IdType="pubmed">34659237</ArticleId></ArticleIdList></Reference><Reference><Citation>Schultz BM, Melo-Gonz&#xe1;lez F, Duarte LF, G&#xe1;lvez NMS, Pacheco GA, Soto JA, et al. . A booster dose of coronaVac increases neutralizing antibodies and T cells that recognize delta and omicron variants of concern. MBio. (2022) 13:e0142322. doi:&#xa0;10.1128/MBIO.01423-22</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/MBIO.01423-22</ArticleId><ArticleId IdType="pmc">PMC9426482</ArticleId><ArticleId IdType="pubmed">35946814</ArticleId></ArticleIdList></Reference><Reference><Citation>Reyes H, Diethelm-Varela B, M&#xe9;ndez C, Rebolledo-Zelada D, Lillo-Dapremont B, Mu&#xf1;oz SR, et al. . Contribution of two-dose vaccination toward the reduction of COVID-19 cases, ICU hospitalizations and deaths in Chile assessed through explanatory generalized additive models for location, scale, and shape. Front Public Heal. (2022) 10:815036. doi:&#xa0;10.3389/fpubh.2022.815036</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fpubh.2022.815036</ArticleId><ArticleId IdType="pmc">PMC9364872</ArticleId><ArticleId IdType="pubmed">35968462</ArticleId></ArticleIdList></Reference><Reference><Citation>G&#xe1;lvez NMS, Pacheco GA, Schultz BM, Melo-Gonz&#xe1;lez F, Soto JA, Duarte LF, et al. . Differences in the immune response elicited by two immunization schedules with an inactivated SARS-CoV-2 vaccine in a randomized phase 3 clinical trial. Elife. (2022) 11:e81477. doi:&#xa0;10.7554/ELIFE.81477</Citation><ArticleIdList><ArticleId IdType="doi">10.7554/ELIFE.81477</ArticleId><ArticleId IdType="pmc">PMC9596164</ArticleId><ArticleId IdType="pubmed">36226829</ArticleId></ArticleIdList></Reference><Reference><Citation>M&#xe9;ndez C, Pe&#xf1;aloza HF, Schultz BM, Pi&#xf1;a-Iturbe A, R&#xed;os M, Moreno-Tapia D, et al. . Humoral and cellular response induced by a second booster of an inactivated SARS-CoV-2 vaccine in adults. EBioMedicine. (2023) 91:652. doi:&#xa0;10.1016/J.EBIOM.2023.104563</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/J.EBIOM.2023.104563</ArticleId><ArticleId IdType="pmc">PMC10129368</ArticleId><ArticleId IdType="pubmed">37099842</ArticleId></ArticleIdList></Reference><Reference><Citation>Antonelli M, Penfold RS, Merino J, Sudre CH, Molteni E, Berry S, et al. . Risk factors and disease profile of post-vaccination SARS-CoV-2 infection in UK users of the COVID Symptom Study app: a prospective, community-based, nested, case-control study. Lancet Infect Dis. (2022) 22:43&#x2013;55. doi:&#xa0;10.1016/S1473-3099(21)00460-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1473-3099(21)00460-6</ArticleId><ArticleId IdType="pmc">PMC8409907</ArticleId><ArticleId IdType="pubmed">34480857</ArticleId></ArticleIdList></Reference><Reference><Citation>Al-Aly Z, Xie Y, Bowe B. High-dimensional characterization of post-acute sequelae of COVID-19. Nature. (2021) 594:259&#x2013;64. doi:&#xa0;10.1038/s41586-021-03553-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-021-03553-9</ArticleId><ArticleId IdType="pubmed">33887749</ArticleId></ArticleIdList></Reference><Reference><Citation>Taquet M, Dercon Q, Harrison PJ. Six-month sequelae of post-vaccination SARS-CoV-2 infection: A retrospective cohort study of 10,024 breakthrough infections. Brain Behav Immun. (2022) 103:154&#x2013;62. doi:&#xa0;10.1016/j.bbi.2022.04.013</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbi.2022.04.013</ArticleId><ArticleId IdType="pmc">PMC9013695</ArticleId><ArticleId IdType="pubmed">35447302</ArticleId></ArticleIdList></Reference><Reference><Citation>Krishna BA, Metaxaki M, Wills MR, Sithole N. Reduced incidence of long coronavirus disease referrals to the cambridge university teaching hospital long coronavirus disease clinic. Clin Infect Dis. (2023) 76:738&#x2013;40. doi:&#xa0;10.1093/CID/CIAC630</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/CID/CIAC630</ArticleId><ArticleId IdType="pmc">PMC9384550</ArticleId><ArticleId IdType="pubmed">35913432</ArticleId></ArticleIdList></Reference><Reference><Citation>Kuodi P, Gorelik Y, Zayyad H, Wertheim O, Wiegler KB, Abu Jabal K, et al. . Association between BNT162b2 vaccination and reported incidence of post-COVID-19 symptoms: cross-sectional study 2020-21, Israel. NPJ Vaccines. (2022) 7:1&#x2013;8. doi:&#xa0;10.1038/s41541-022-00526-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41541-022-00526-5</ArticleId><ArticleId IdType="pmc">PMC9411827</ArticleId><ArticleId IdType="pubmed">36028498</ArticleId></ArticleIdList></Reference><Reference><Citation>Clemens SAC, Weckx L, Clemens R, Mendes AVA, Souza AR, Silveira MBV, et al. . Heterologous versus homologous COVID-19 booster vaccination in previous recipients of two doses of CoronaVac COVID-19 vaccine in Brazil (RHH-001): a phase 4, non-inferiority, single blind, randomised study. Lancet. (2022) 399:521&#x2013;9. doi:&#xa0;10.1016/S0140-6736(22)00094-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(22)00094-0</ArticleId><ArticleId IdType="pmc">PMC8782575</ArticleId><ArticleId IdType="pubmed">35074136</ArticleId></ArticleIdList></Reference><Reference><Citation>Jara A, Undurraga EA, Zubizarreta JR, Gonz&#xe1;lez C, Pizarro A, Acevedo J, et al. . Effectiveness of homologous and heterologous booster doses for an inactivated SARS-CoV-2 vaccine: a large-scale prospective cohort study. Lancet Glob Heal. (2022) 10:e798&#x2013;806. doi:&#xa0;10.1016/S2214-109X(22)00112-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2214-109X(22)00112-7</ArticleId><ArticleId IdType="pmc">PMC9034854</ArticleId><ArticleId IdType="pubmed">35472300</ArticleId></ArticleIdList></Reference><Reference><Citation>Hammond J, Leister-Tebbe H, Gardner A, Abreu P, Bao W, Wisemandle W, et al. . Oral nirmatrelvir for high-risk, nonhospitalized adults with covid-19. N Engl J Med. (2022) 386:1397&#x2013;408. doi:&#xa0;10.1056/NEJMoa2118542</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa2118542</ArticleId><ArticleId IdType="pmc">PMC8908851</ArticleId><ArticleId IdType="pubmed">35172054</ArticleId></ArticleIdList></Reference><Reference><Citation>Kabinger F, Stiller C, Schmitzov&#xe1; J, Dienemann C, Kokic G, Hillen HS, et al. . Mechanism of molnupiravir-induced SARS-CoV-2 mutagenesis. Nat Struct Mol Biol 2021 289. (2021) 28:740&#x2013;6. doi:&#xa0;10.1038/s41594-021-00651-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41594-021-00651-0</ArticleId><ArticleId IdType="pmc">PMC8437801</ArticleId><ArticleId IdType="pubmed">34381216</ArticleId></ArticleIdList></Reference><Reference><Citation>Owen DR, Allerton CMN, Anderson AS, Aschenbrenner L, Avery M, Berritt S, et al. . An oral SARS-CoV-2 Mpro inhibitor clinical candidate for the treatment of COVID-19. Science (80-). (2021) 374:1586&#x2013;93. doi:&#xa0;10.1126/SCIENCE.ABL4784/SUPPL_FILE/SCIENCE.ABL4784_MDAR_REPRODUCIBILITY_CHECKLIST.PDF</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/SCIENCE.ABL4784/SUPPL_FILE/SCIENCE.ABL4784_MDAR_REPRODUCIBILITY_CHECKLIST.PDF</ArticleId><ArticleId IdType="pubmed">34726479</ArticleId></ArticleIdList></Reference><Reference><Citation>Xie Y, Choi T, Al-Aly Z. Association of treatment with nirmatrelvir and the risk of post-COVID-19 condition. JAMA Intern Med. (2023) 183:554&#x2013;64. doi:&#xa0;10.1001/JAMAINTERNMED.2023.0743</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/JAMAINTERNMED.2023.0743</ArticleId><ArticleId IdType="pmc">PMC10037200</ArticleId><ArticleId IdType="pubmed">36951829</ArticleId></ArticleIdList></Reference><Reference><Citation>Xie Y, Choi T, Al-Aly Z. Molnupiravir and risk of post-acute sequelae of covid-19: cohort study. BMJ. (2023) 381:e074572. doi:&#xa0;10.1136/BMJ-2022-074572</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/BMJ-2022-074572</ArticleId><ArticleId IdType="pmc">PMC10126525</ArticleId><ArticleId IdType="pubmed">37161995</ArticleId></ArticleIdList></Reference><Reference><Citation>Kuczborska K, Buda P, Ksi&#x105;&#x17c;yk J. Long-COVID in immunocompromised children. Eur J Pediatr. (2022) 181:3501&#x2013;9. doi:&#xa0;10.1007/s00431-022-04561-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00431-022-04561-1</ArticleId><ArticleId IdType="pmc">PMC9281224</ArticleId><ArticleId IdType="pubmed">35834042</ArticleId></ArticleIdList></Reference><Reference><Citation>Arnold DT, Milne A, Samms E, Stadon L, Maskell NA, Hamilton FW. Symptoms after COVID-19 vaccination in patients with persistent symptoms after acute infection: A case series. Ann Intern Med. (2021) 174:1334&#x2013;6. doi:&#xa0;10.7326/M21-1976</Citation><ArticleIdList><ArticleId IdType="doi">10.7326/M21-1976</ArticleId><ArticleId IdType="pmc">PMC8252827</ArticleId><ArticleId IdType="pubmed">34029484</ArticleId></ArticleIdList></Reference><Reference><Citation>Ayoubkhani D, Bermingham C, Pouwels KB, Glickman M, Nafilyan V, Zaccardi F, et al. . Trajectory of long covid symptoms after covid-19 vaccination: community based cohort study. BMJ. (2022) 377:e069676. doi:&#xa0;10.1136/bmj-2021-069676</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj-2021-069676</ArticleId><ArticleId IdType="pmc">PMC9115603</ArticleId><ArticleId IdType="pubmed">35584816</ArticleId></ArticleIdList></Reference><Reference><Citation>Izquierdo-Pujol J, Moron-Lopez S, Dalmau J, Gonzalez-Aumatell A, Carreras-Abad C, Mendez M, et al. . Post COVID-19 condition in children and adolescents: an emerging problem. Front Pediatr. (2022) 10:894204. doi:&#xa0;10.3389/fped.2022.894204</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fped.2022.894204</ArticleId><ArticleId IdType="pmc">PMC9130634</ArticleId><ArticleId IdType="pubmed">35633949</ArticleId></ArticleIdList></Reference><Reference><Citation>Smane L, Roge I, Pucuka Z, Pavare J. Clinical features of pediatric post-acute COVID-19: a descriptive retrospective follow-up study. Ital J Pediatr. (2021) 47:177. doi:&#xa0;10.1186/s13052-021-01127-z</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13052-021-01127-z</ArticleId><ArticleId IdType="pmc">PMC8390049</ArticleId><ArticleId IdType="pubmed">34446085</ArticleId></ArticleIdList></Reference><Reference><Citation>Ludvigsson JF. Case report and systematic review suggest that children may experience similar long-term effects to adults after clinical COVID-19. Acta Paediatr. (2021) 110:914&#x2013;21. doi:&#xa0;10.1111/apa.15673</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/apa.15673</ArticleId><ArticleId IdType="pmc">PMC7753397</ArticleId><ArticleId IdType="pubmed">33205450</ArticleId></ArticleIdList></Reference><Reference><Citation>Anaya J-M, Rojas M, Salinas ML, Rodr&#xed;guez Y, Roa G, Lozano M, et al. . Post-COVID syndrome. A case series and comprehensive review. Autoimmun Rev. (2021) 20:102947. doi:&#xa0;10.1016/j.autrev.2021.102947</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.autrev.2021.102947</ArticleId><ArticleId IdType="pmc">PMC8428988</ArticleId><ArticleId IdType="pubmed">34509649</ArticleId></ArticleIdList></Reference><Reference><Citation>Castanares-Zapatero D, Chalon P, Kohn L, Dauvrin M, Detollenaere J, de Noordhout CM, et al. . Pathophysiology and mechanism of long COVID: a comprehensive review. Ann Med. (2022) 54:1473&#x2013;87. doi:&#xa0;10.1080/07853890.2022.2076901</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/07853890.2022.2076901</ArticleId><ArticleId IdType="pmc">PMC9132392</ArticleId><ArticleId IdType="pubmed">35594336</ArticleId></ArticleIdList></Reference><Reference><Citation>Cheon IS, Li C, Son YM, Goplen NP, Wu Y, Cassmann T, et al. . Immune signatures underlying post-acute COVID-19 lung sequelae. Sci Immunol. (2021) 6:eabk1741. doi:&#xa0;10.1126/sciimmunol.abk1741</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/sciimmunol.abk1741</ArticleId><ArticleId IdType="pmc">PMC8763087</ArticleId><ArticleId IdType="pubmed">34591653</ArticleId></ArticleIdList></Reference><Reference><Citation>Fern&#xe1;ndez-L&#xe1;zaro D, S&#xe1;nchez-Serrano N, Mielgo-Ayuso J, Garc&#xed;a-Hern&#xe1;ndez JL, Gonz&#xe1;lez-Bernal JJ, Seco-Calvo J. Long COVID a new derivative in the chaos of SARS-coV-2 infection: the emergent pandemic? J Clin Med. (2021) 10:5799. doi:&#xa0;10.3390/jcm10245799</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcm10245799</ArticleId><ArticleId IdType="pmc">PMC8708091</ArticleId><ArticleId IdType="pubmed">34945095</ArticleId></ArticleIdList></Reference><Reference><Citation>Ong SWX, Fong S-W, Young BE, Chan Y-H, Lee B, Amrun SN, et al. . Persistent symptoms and association with inflammatory cytokine signatures in recovered coronavirus disease 2019 patients. Open Forum Infect Dis. (2021) 8:ofab156. doi:&#xa0;10.1093/ofid/ofab156</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ofid/ofab156</ArticleId><ArticleId IdType="pmc">PMC8083585</ArticleId><ArticleId IdType="pubmed">34095336</ArticleId></ArticleIdList></Reference><Reference><Citation>Krishna B, Lim E, Mactavous L, Jackson S, Team NBTNB. Lyons P, et al. . Spontaneous, persistent T-cell dependent IFN-&#x3b3; release in patients who progress to Long COVID. (2022). doi:&#xa0;10.21203/RS.3.RS-2034285/V2</Citation><ArticleIdList><ArticleId IdType="doi">10.21203/RS.3.RS-2034285/V2</ArticleId><ArticleId IdType="pmc">PMC10881041</ArticleId><ArticleId IdType="pubmed">38381822</ArticleId></ArticleIdList></Reference><Reference><Citation>Opsteen S, Files JK, Fram T, Erdmann N. The role of immune activation and antigen persistence in acute and long COVID. J Investig Med. (2023) 71:545&#x2013;62. doi:&#xa0;10.1177/10815589231158041</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/10815589231158041</ArticleId><ArticleId IdType="pmc">PMC9996119</ArticleId><ArticleId IdType="pubmed">36879504</ArticleId></ArticleIdList></Reference><Reference><Citation>Littlefield KM, Watson RO, Schneider JM, Neff CP, Yamada E, Zhang M, et al. . SARS-CoV-2-specific T cells associate with inflammation and reduced lung function in pulmonary post-acute sequalae of SARS-CoV-2. PloS Pathog. (2022) 18:e1010359. doi:&#xa0;10.1371/JOURNAL.PPAT.1010359</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/JOURNAL.PPAT.1010359</ArticleId><ArticleId IdType="pmc">PMC9176759</ArticleId><ArticleId IdType="pubmed">35617421</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen N, Zhou M, Dong X, Qu J, Gong F, Han Y, et al. . Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet. (2020) 395:507&#x2013;13. doi:&#xa0;10.1016/S0140-6736(20)30211-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(20)30211-7</ArticleId><ArticleId IdType="pmc">PMC7135076</ArticleId><ArticleId IdType="pubmed">32007143</ArticleId></ArticleIdList></Reference><Reference><Citation>Daher A, Cornelissen C, Hartmann NU, Balfanz P, M&#xfc;ller A, Bergs I, et al. . Six months follow-up of patients with invasive mechanical ventilation due to COVID-19 related ARDS. Int J Environ Res Public Health. (2021) 18. doi:&#xa0;10.3390/IJERPH18115861</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/IJERPH18115861</ArticleId><ArticleId IdType="pmc">PMC8199360</ArticleId><ArticleId IdType="pubmed">34072557</ArticleId></ArticleIdList></Reference><Reference><Citation>Sayde GE, Stefanescu A, Hammer R. Interdisciplinary treatment for survivors of critical illness due to COVID-19: expanding the post-intensive care recovery model and impact on psychiatric outcomes. J Acad Consult Psychiatry. (2023) 64:226&#x2013;35. doi:&#xa0;10.1016/J.JACLP.2023.01.009</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/J.JACLP.2023.01.009</ArticleId><ArticleId IdType="pmc">PMC9884613</ArticleId><ArticleId IdType="pubmed">36720311</ArticleId></ArticleIdList></Reference><Reference><Citation>Irisson-Mora I, Salgado-Cordero AM, Reyes-Var&#xf3;n E, Cataneo-Pi&#xf1;a DJ, Fern&#xe1;ndez-S&#xe1;nchez M, Buend&#xed;a-Rold&#xe1;n I, et al. . Comparison between the persistence of post COVID-19 symptoms on critical patients requiring invasive mechanical ventilation and non-critical patients. PloS One. (2022) 17:e0273041. doi:&#xa0;10.1371/JOURNAL.PONE.0273041</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/JOURNAL.PONE.0273041</ArticleId><ArticleId IdType="pmc">PMC9394845</ArticleId><ArticleId IdType="pubmed">35994441</ArticleId></ArticleIdList></Reference><Reference><Citation>Karnatovskaia LV, Schulte PJ, Philbrick KL, Johnson MM, Anderson BK, Gajic O, et al. . Psychocognitive sequelae of critical illness and correlation with 3 months follow up. J Crit Care. (2019) 52:166&#x2013;71. doi:&#xa0;10.1016/J.JCRC.2019.04.028</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/J.JCRC.2019.04.028</ArticleId><ArticleId IdType="pubmed">31078997</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee AM, Wong JGWS, McAlonan GM, Cheung V, Cheung C, Sham PC, et al. . Stress and psychological distress among SARS survivors 1 year after the outbreak. Can J Psychiatry. (2007) 52:233&#x2013;40. doi:&#xa0;10.1177/070674370705200405</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/070674370705200405</ArticleId><ArticleId IdType="pubmed">17500304</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee SH, Shin HS, Park HY, Kim JL, Lee JJ, Lee H, et al. . Depression as a mediator of chronic fatigue and post-traumatic stress symptoms in middle east respiratory syndrome survivors. Psychiatry Investig. (2019) 16:59. doi:&#xa0;10.30773/pi.2018.10.22.3</Citation><ArticleIdList><ArticleId IdType="doi">10.30773/pi.2018.10.22.3</ArticleId><ArticleId IdType="pmc">PMC6354037</ArticleId><ArticleId IdType="pubmed">30605995</ArticleId></ArticleIdList></Reference><Reference><Citation>Mateo Rodr&#xed;guez E, PuChades Gimeno F, Ezzeddine Angulo A, Asensio Samper J, Saiz Ruiz C, L&#xf3;pez Alarc&#xf3;n MD. Postintensive care syndrome in COVID-19. Unicentric pilot study. Calm does not come after the storm. Med Clin (English ed). (2022) 159:321&#x2013;6. doi:&#xa0;10.1016/J.MEDCLE.2021.11.013</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/J.MEDCLE.2021.11.013</ArticleId><ArticleId IdType="pmc">PMC9441718</ArticleId><ArticleId IdType="pubmed">36091872</ArticleId></ArticleIdList></Reference><Reference><Citation>Freeman A, Tyrovolas S, Koyanagi A, Chatterji S, Leonardi M, Ayuso-Mateos JL, et al. . The role of socio-economic status in depression: results from the COURAGE (aging survey in Europe). BMC Public Health. (2016) 16:1098. doi:&#xa0;10.1186/S12889-016-3638-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/S12889-016-3638-0</ArticleId><ArticleId IdType="pmc">PMC5069819</ArticleId><ArticleId IdType="pubmed">27760538</ArticleId></ArticleIdList></Reference><Reference><Citation>Saeidi M, Safaei A, Sadat Z, Abbasi P, Sarcheshmeh MSM, Dehghani F, et al. . Prevalence of depression, anxiety and stress among patients discharged from critical care units. J Crit Care Med. (2021) 7:113. doi:&#xa0;10.2478/JCCM-2021-0012</Citation><ArticleIdList><ArticleId IdType="doi">10.2478/JCCM-2021-0012</ArticleId><ArticleId IdType="pmc">PMC8519366</ArticleId><ArticleId IdType="pubmed">34722912</ArticleId></ArticleIdList></Reference><Reference><Citation>Klok FA, Boon GJAM, Barco S, Endres M, Geelhoed JJM, Knauss S, et al. . The Post-COVID-19 Functional Status scale: a tool to measure functional status over time after COVID-19. Eur Respir J. (2020) 56:2001494. doi:&#xa0;10.1183/13993003.01494-2020</Citation><ArticleIdList><ArticleId IdType="doi">10.1183/13993003.01494-2020</ArticleId><ArticleId IdType="pmc">PMC7236834</ArticleId><ArticleId IdType="pubmed">32398306</ArticleId></ArticleIdList></Reference><Reference><Citation>Nopp S, Moik F, Klok FA, Gattinger D, Petrovic M, Vonbank K, et al. . Outpatient pulmonary rehabilitation in patients with long COVID improves exercise capacity, functional status, dyspnea, fatigue, and quality of life. Respiration. (2022) 101:593&#x2013;601. doi:&#xa0;10.1159/000522118</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000522118</ArticleId><ArticleId IdType="pmc">PMC9059007</ArticleId><ArticleId IdType="pubmed">35203084</ArticleId></ArticleIdList></Reference><Reference><Citation>MaChado FVC, Meys R, Delbressine JM, Vaes AW, Go&#xeb;rtz YMJ, van Herck M, et al. . Construct validity of the Post-COVID-19 Functional Status Scale in adult subjects with COVID-19. Health Qual Life Outcomes. (2021) 19:40. doi:&#xa0;10.1186/s12955-021-01691-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12955-021-01691-2</ArticleId><ArticleId IdType="pmc">PMC7856622</ArticleId><ArticleId IdType="pubmed">33536042</ArticleId></ArticleIdList></Reference><Reference><Citation>Gargon E, Gorst SL, Matvienko-Sikar K, Williamson PR. Choosing important health outcomes for comparative effectiveness research: 6th annual update to a systematic review of core outcome sets for research. PloS One. (2021) 16:e0244878. doi:&#xa0;10.1371/journal.pone.0244878</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0244878</ArticleId><ArticleId IdType="pmc">PMC7802923</ArticleId><ArticleId IdType="pubmed">33434219</ArticleId></ArticleIdList></Reference><Reference><Citation>Munblit D, Nicholson T, Akrami A, Apfelbacher C, Chen J, De Groote W, et al. . A core outcome set for post-COVID-19 condition in adults for use in clinical practice and research: an international Delphi consensus study. Lancet Respir Med. (2022) 10:715&#x2013;24. doi:&#xa0;10.1016/S2213-2600(22)00169-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2213-2600(22)00169-2</ArticleId><ArticleId IdType="pmc">PMC9197249</ArticleId><ArticleId IdType="pubmed">35714658</ArticleId></ArticleIdList></Reference><Reference><Citation>Williamson PR, Altman DG, Bagley H, Barnes KL, Blazeby JM, Brookes ST, et al. . The COMET handbook: version 1.0. Trials. (2017) 18:280. doi:&#xa0;10.1186/s13063-017-1978-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13063-017-1978-4</ArticleId><ArticleId IdType="pmc">PMC5499094</ArticleId><ArticleId IdType="pubmed">28681707</ArticleId></ArticleIdList></Reference><Reference><Citation>
Foundation ER . EQ-5D user guides (2022). Available online at: https://euroqol.org/publications/user-guides/.</Citation></Reference><Reference><Citation>
on Disability Statistics TWG . WG short set on functioning (WG-SS) (2022). Available online at: https://www.washingtongroup-disability.com/question-sets/wg-short-set-on-functioning-wg-ss/.</Citation></Reference><Reference><Citation>Dani M, Dirksen A, Taraborrelli P, Torocastro M, Panagopoulos D, Sutton R, et al. . Autonomic dysfunction in &#x2018;long COVID&#x2019;: rationale, physiology and management strategies. Clin Med (Northfield Il). (2021) 21:e63&#x2013;7. doi:&#xa0;10.7861/clinmed.2020-0896</Citation><ArticleIdList><ArticleId IdType="doi">10.7861/clinmed.2020-0896</ArticleId><ArticleId IdType="pmc">PMC7850225</ArticleId><ArticleId IdType="pubmed">33243837</ArticleId></ArticleIdList></Reference><Reference><Citation>Mandal S, Barnett J, Brill SE, Brown JS, Denneny EK, Hare SS, et al. . &#x2018;Long-COVID&#x2019;: a cross-sectional study of persisting symptoms, biomarker and imaging abnormalities following hospitalisation for COVID-19. Thorax. (2021) 76:396&#x2013;8. doi:&#xa0;10.1136/thoraxjnl-2020-215818</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/thoraxjnl-2020-215818</ArticleId><ArticleId IdType="pmc">PMC7615158</ArticleId><ArticleId IdType="pubmed">33172844</ArticleId></ArticleIdList></Reference><Reference><Citation>Saini G, Aneja R. Cancer as a prospective sequela of long COVID-19. BioEssays. (2021) 43:2000331. doi:&#xa0;10.1002/bies.202000331</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/bies.202000331</ArticleId><ArticleId IdType="pmc">PMC8206711</ArticleId><ArticleId IdType="pubmed">33914346</ArticleId></ArticleIdList></Reference><Reference><Citation>Davis HE, Assaf GS, McCorkell L, Wei H, Low RJ, Re&#x2019;em Y, et al. . Characterizing long COVID in an international cohort: 7 months of symptoms and their impact. EClinicalMedicine. (2021) 38:101019. doi:&#xa0;10.1016/j.eclinm.2021.101019</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.eclinm.2021.101019</ArticleId><ArticleId IdType="pmc">PMC8280690</ArticleId><ArticleId IdType="pubmed">34308300</ArticleId></ArticleIdList></Reference><Reference><Citation>Colarusso C, Maglio A, Terlizzi M, Vitale C, Molino A, Pinto A, et al. . Post-COVID-19 patients who develop lung fibrotic-like changes have lower circulating levels of IFN-&#x3b2; but higher levels of IL-1&#x3b1; and TGF-&#x3b2;. Biomedicines. (2021) 9:1931. doi:&#xa0;10.3390/biomedicines9121931</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/biomedicines9121931</ArticleId><ArticleId IdType="pmc">PMC8698335</ArticleId><ArticleId IdType="pubmed">34944747</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang F, Kream RM, Stefano GB. Long-term respiratory and neurological sequelae of COVID-19. Med Sci Monit. (2020) 26:1&#x2013;10. doi:&#xa0;10.12659/MSM.928996</Citation><ArticleIdList><ArticleId IdType="doi">10.12659/MSM.928996</ArticleId><ArticleId IdType="pmc">PMC7643287</ArticleId><ArticleId IdType="pubmed">33177481</ArticleId></ArticleIdList></Reference><Reference><Citation>Ackermann M, Mentzer SJ, Kolb M, Jonigk D. Inflammation and intussusceptive angiogenesis in COVID-19: everything in and out of flow. Eur Respir J. (2020) 56:2003147. doi:&#xa0;10.1183/13993003.03147-2020</Citation><ArticleIdList><ArticleId IdType="doi">10.1183/13993003.03147-2020</ArticleId><ArticleId IdType="pmc">PMC7530910</ArticleId><ArticleId IdType="pubmed">33008942</ArticleId></ArticleIdList></Reference><Reference><Citation>Hampshire A, Trender W, Chamberlain SR, Jolly AE, Grant JE, Patrick F, et al. . Cognitive deficits in people who have recovered from COVID-19. EClinicalMedicine. (2021) 39:101044. doi:&#xa0;10.1016/j.eclinm.2021.101044</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.eclinm.2021.101044</ArticleId><ArticleId IdType="pmc">PMC8298139</ArticleId><ArticleId IdType="pubmed">34316551</ArticleId></ArticleIdList></Reference><Reference><Citation>Song W-J, Hui CKM, Hull JH, Birring SS, McGarvey L, Mazzone SB, et al. . Confronting COVID-19-associated cough and the post-COVID syndrome: role of viral neurotropism, neuroinflammation, and neuroimmune responses. Lancet Respir Med. (2021) 9:533&#x2013;44. doi:&#xa0;10.1016/S2213-2600(21)00125-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2213-2600(21)00125-9</ArticleId><ArticleId IdType="pmc">PMC8041436</ArticleId><ArticleId IdType="pubmed">33857435</ArticleId></ArticleIdList></Reference><Reference><Citation>Chopra V, Flanders SA, O&#x2019;Malley M, Malani AN, Prescott HC. Sixty-day outcomes among patients hospitalized with COVID-19. Ann Intern Med. (2021) 174:576&#x2013;8. doi:&#xa0;10.7326/M20-5661</Citation><ArticleIdList><ArticleId IdType="doi">10.7326/M20-5661</ArticleId><ArticleId IdType="pmc">PMC7707210</ArticleId><ArticleId IdType="pubmed">33175566</ArticleId></ArticleIdList></Reference><Reference><Citation>Petersen MS, Kristiansen MF, Hanusson KD, Danielsen ME, &#xe1; Steig B, Gaini S, et al. . Long COVID in the Faroe Islands: A longitudinal study among nonhospitalized patients. Clin Infect Dis. (2021) 73:e4058&#x2013;63. doi:&#xa0;10.1093/cid/ciaa1792</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cid/ciaa1792</ArticleId><ArticleId IdType="pmc">PMC7799340</ArticleId><ArticleId IdType="pubmed">33252665</ArticleId></ArticleIdList></Reference><Reference><Citation>Evans RA, Leavy OC, Richardson M, Elneima O, McAuley HJC, Shikotra A, et al. . Clinical characteristics with inflammation profiling of long COVID and association with 1-year recovery following hospitalisation in the UK: a prospective observational study. Lancet Respir Med. (2022) 10:761&#x2013;75. doi:&#xa0;10.1016/S2213-2600(22)00127-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2213-2600(22)00127-8</ArticleId><ArticleId IdType="pmc">PMC9034855</ArticleId><ArticleId IdType="pubmed">35472304</ArticleId></ArticleIdList></Reference><Reference><Citation>Scott NA, Pearmain L, Knight SB, Brand O, Morgan DJ, Jagger C, et al. . Monocyte migration profiles define disease severity in acute COVID-19 and unique features of long COVID. Eur Respir J. (2023) 61:2202226. doi:&#xa0;10.1183/13993003.02226-2022</Citation><ArticleIdList><ArticleId IdType="doi">10.1183/13993003.02226-2022</ArticleId><ArticleId IdType="pmc">PMC10040898</ArticleId><ArticleId IdType="pubmed">36922030</ArticleId></ArticleIdList></Reference><Reference><Citation>Zheng B, Daines L, Han Q, Hurst JR, Pfeffer P, Shankar-Hari M, et al. . Prevalence, risk factors and treatments for post-COVID-19 breathlessness: a systematic review and meta-analysis. Eur Respir Rev. (2022) 31. doi:&#xa0;10.1183/16000617.0071-2022</Citation><ArticleIdList><ArticleId IdType="doi">10.1183/16000617.0071-2022</ArticleId><ArticleId IdType="pmc">PMC9724798</ArticleId><ArticleId IdType="pubmed">36323418</ArticleId></ArticleIdList></Reference><Reference><Citation>Fern&#xe1;ndez-de-las-Pe&#xf1;as C, Cancela-Cilleruelo I, Rodr&#xed;guez-Jim&#xe9;nez J, Fuensalida-Novo S, Mart&#xed;n-Guerrero JD, Pellicer-Valero OJ, et al. . Trajectory of post-COVID self-reported fatigue and dyspnoea in individuals who had been hospitalized by COVID-19: the LONG-COVID-EXP multicenter study. Biomed. (2023) 11:1863. doi:&#xa0;10.3390/BIOMEDICINES11071863</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/BIOMEDICINES11071863</ArticleId><ArticleId IdType="pmc">PMC10376654</ArticleId><ArticleId IdType="pubmed">37509504</ArticleId></ArticleIdList></Reference><Reference><Citation>Delorey TM, Ziegler CGK, Heimberg G, Normand R, Yang Y, Segerstolpe &#xc5;, et al. . COVID-19 tissue atlases reveal SARS-CoV-2 pathology and cellular targets. Nature. (2021) 595:107&#x2013;13. doi:&#xa0;10.1038/s41586-021-03570-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-021-03570-8</ArticleId><ArticleId IdType="pmc">PMC8919505</ArticleId><ArticleId IdType="pubmed">33915569</ArticleId></ArticleIdList></Reference><Reference><Citation>Merad M, Blish CA, Sallusto F, Iwasaki A. The immunology and immunopathology of COVID-19. Science (80-). (2022) 375:1122&#x2013;7. doi:&#xa0;10.1126/science.abm8108</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.abm8108</ArticleId><ArticleId IdType="pubmed">35271343</ArticleId></ArticleIdList></Reference><Reference><Citation>Montefusco L, Ben Nasr M, D&#x2019;Addio F, Loretelli C, Rossi A, Pastore I, et al. . Acute and long-term disruption of glycometabolic control after SARS-CoV-2 infection. Nat Metab. (2021) 3:774&#x2013;85. doi:&#xa0;10.1038/s42255-021-00407-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s42255-021-00407-6</ArticleId><ArticleId IdType="pmc">PMC9931026</ArticleId><ArticleId IdType="pubmed">34035524</ArticleId></ArticleIdList></Reference><Reference><Citation>Hadjadj J, Yatim N, Barnabei L, Corneau A, Boussier J, Smith N, et al. . Impaired type I interferon activity and inflammatory responses in severe COVID-19 patients. Science (80-). (2020) 369:718&#x2013;24. doi:&#xa0;10.1126/science.abc6027</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.abc6027</ArticleId><ArticleId IdType="pmc">PMC7402632</ArticleId><ArticleId IdType="pubmed">32661059</ArticleId></ArticleIdList></Reference><Reference><Citation>Del Valle DM, Kim-Schulze S, Huang H-H, Beckmann ND, Nirenberg S, Wang B, et al. . An inflammatory cytokine signature predicts COVID-19 severity and survival. Nat Med. (2020) 26:1636&#x2013;43. doi:&#xa0;10.1038/s41591-020-1051-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-020-1051-9</ArticleId><ArticleId IdType="pmc">PMC7869028</ArticleId><ArticleId IdType="pubmed">32839624</ArticleId></ArticleIdList></Reference><Reference><Citation>Lucas C, Wong P, Klein J, Castro TBR, Silva J, Sundaram M, et al. . Longitudinal analyses reveal immunological misfiring in severe COVID-19. Nature. (2020) 584:463&#x2013;9. doi:&#xa0;10.1038/s41586-020-2588-y</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-020-2588-y</ArticleId><ArticleId IdType="pmc">PMC7477538</ArticleId><ArticleId IdType="pubmed">32717743</ArticleId></ArticleIdList></Reference><Reference><Citation>Rodrigues TS, de S&#xe1; KSG, Ishimoto AY, Becerra A, Oliveira S, Almeida L, et al. . Inflammasomes are activated in response to SARS-CoV-2 infection and are associated with COVID-19 severity in patients. J Exp Med. (2021) 218:e20201707. doi:&#xa0;10.1084/jem.20201707</Citation><ArticleIdList><ArticleId IdType="doi">10.1084/jem.20201707</ArticleId><ArticleId IdType="pmc">PMC7684031</ArticleId><ArticleId IdType="pubmed">33231615</ArticleId></ArticleIdList></Reference><Reference><Citation>Sefik E, Qu R, Junqueira C, Kaffe E, Mirza H, Zhao J, et al. . Inflammasome activation in infected macrophages drives COVID-19 pathology. Nature. (2022) 606:585&#x2013;93. doi:&#xa0;10.1038/s41586-022-04802-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-022-04802-1</ArticleId><ArticleId IdType="pmc">PMC9288243</ArticleId><ArticleId IdType="pubmed">35483404</ArticleId></ArticleIdList></Reference><Reference><Citation>Khan W, Safi A, Muneeb M, Mooghal M, Aftab A, Ahmed J. Complications of invasive mechanical ventilation in critically Ill Covid-19 patients - A narrative review. Ann Med Surg. (2022) 80:104201. doi:&#xa0;10.1016/J.AMSU.2022.104201</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/J.AMSU.2022.104201</ArticleId><ArticleId IdType="pmc">PMC9287581</ArticleId><ArticleId IdType="pubmed">35874936</ArticleId></ArticleIdList></Reference><Reference><Citation>Steinbeis F, Thibeault C, Doellinger F, Ring RM, Mittermaier M, Ruwwe-Gl&#xf6;senkamp C, et al. . Severity of respiratory failure and computed chest tomography in acute COVID-19 correlates with pulmonary function and respiratory symptoms after infection with SARS-CoV-2: An observational longitudinal study over 12 months. Respir Med. (2022) 191:106709. doi:&#xa0;10.1016/J.RMED.2021.106709</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/J.RMED.2021.106709</ArticleId><ArticleId IdType="pmc">PMC8632363</ArticleId><ArticleId IdType="pubmed">34871947</ArticleId></ArticleIdList></Reference><Reference><Citation>Ibrahim GS, Alkandari BM, Shady IAA, Gupta VK, Abdelmohsen MA. Invasive mechanical ventilation complications in COVID-19 patients. Egypt J Radiol Nucl Med. (2021) 52:226. doi:&#xa0;10.1186/S43055-021-00609-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/S43055-021-00609-8</ArticleId></ArticleIdList></Reference><Reference><Citation>Pierson DJ. Complications associated with mechanical ventilation. Crit Care Clin. (1990) 6:711&#x2013;24. doi:&#xa0;10.1016/S0749-0704(18)30362-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0749-0704(18)30362-2</ArticleId><ArticleId IdType="pubmed">2199002</ArticleId></ArticleIdList></Reference><Reference><Citation>Beitler JR, Malhotra A, Thompson BT. Ventilator-induced lung injury. Clin Chest Med. (2016) 37:633&#x2013;46. doi:&#xa0;10.1016/J.CCM.2016.07.004</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/J.CCM.2016.07.004</ArticleId><ArticleId IdType="pmc">PMC5131805</ArticleId><ArticleId IdType="pubmed">27842744</ArticleId></ArticleIdList></Reference><Reference><Citation>Farghaly S, Badedi M, Ibrahim R, Sadhan MH, Alamoudi A, Alnami A, et al. . Clinical characteristics and outcomes of post-COVID-19 pulmonary fibrosis: A case-control study. Med (Baltimore). (2022) 101:E28639. doi:&#xa0;10.1097/MD.0000000000028639</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/MD.0000000000028639</ArticleId><ArticleId IdType="pmc">PMC8772621</ArticleId><ArticleId IdType="pubmed">35060549</ArticleId></ArticleIdList></Reference><Reference><Citation>Rogers JP, Chesney E, Oliver D, Pollak TA, McGuire P, Fusar-Poli P, et al. . Psychiatric and neuropsychiatric presentations associated with severe coronavirus infections: a systematic review and meta-analysis with comparison to the COVID-19 pandemic. Lancet Psychiatry. (2020) 7:611&#x2013;27. doi:&#xa0;10.1016/S2215-0366(20)30203-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2215-0366(20)30203-0</ArticleId><ArticleId IdType="pmc">PMC7234781</ArticleId><ArticleId IdType="pubmed">32437679</ArticleId></ArticleIdList></Reference><Reference><Citation>Baig AM. Deleterious outcomes in long-hauler COVID-19: the effects of SARS-coV-2 on the CNS in chronic COVID syndrome. ACS Chem Neurosci. (2020) 11:4017&#x2013;20. doi:&#xa0;10.1021/acschemneuro.0c00725</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/acschemneuro.0c00725</ArticleId><ArticleId IdType="pubmed">33275404</ArticleId></ArticleIdList></Reference><Reference><Citation>Shimohata T. Neuro-COVID-19. Clin Exp Neuroimmunol. (2022) 13:17&#x2013;23. doi:&#xa0;10.1111/cen3.12676</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/cen3.12676</ArticleId><ArticleId IdType="pmc">PMC8652810</ArticleId><ArticleId IdType="pubmed">34899999</ArticleId></ArticleIdList></Reference><Reference><Citation>Bohmwald K, G&#xe1;lvez NMS, R&#xed;os M, Kalergis AM. Neurologic alterations due to respiratory virus infections. Front Cell Neurosci. (2018) 12:386. doi:&#xa0;10.3389/fncel.2018.00386</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fncel.2018.00386</ArticleId><ArticleId IdType="pmc">PMC6212673</ArticleId><ArticleId IdType="pubmed">30416428</ArticleId></ArticleIdList></Reference><Reference><Citation>Bohmwald K, Andrade CA, Kalergis AM. Contribution of pro-inflammatory molecules induced by respiratory virus infections to neurological disorders. Pharmaceuticals. (2021) 14:340. doi:&#xa0;10.3390/ph14040340</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ph14040340</ArticleId><ArticleId IdType="pmc">PMC8068239</ArticleId><ArticleId IdType="pubmed">33917837</ArticleId></ArticleIdList></Reference><Reference><Citation>Uribe FR, Gonz&#xe1;lez VPI, Kalergis AM, Soto JA, Bohmwald K. Understanding the neurotrophic virus mechanisms and their potential effect on systemic lupus erythematosus development. Brain Sci. (2024) 14:59. doi:&#xa0;10.3390/BRAINSCI14010059</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/BRAINSCI14010059</ArticleId><ArticleId IdType="pmc">PMC10813552</ArticleId><ArticleId IdType="pubmed">38248274</ArticleId></ArticleIdList></Reference><Reference><Citation>Camacho-Concha N, Santana-Rom&#xe1;n ME, S&#xe1;nchez NC, Velasco I, Pando-Robles V, Pedraza-Alva G, et al. . Insights into zika virus pathogenesis and potential therapeutic strategies. Biomedicines. (2023) 11:3316. doi:&#xa0;10.3390/BIOMEDICINES11123316</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/BIOMEDICINES11123316</ArticleId><ArticleId IdType="pmc">PMC10741857</ArticleId><ArticleId IdType="pubmed">38137537</ArticleId></ArticleIdList></Reference><Reference><Citation>Riedel C, Rivera JC, Canedo-Marroqu&#xed;n G, Kalergis AM, Opazo MC. Respiratory viral infections during pregnancy: effects of SARS-CoV-2 and other related viruses over the offspring. J Dev Orig Health Dis. (2022) 13:3&#x2013;8. doi:&#xa0;10.1017/S2040174420001373</Citation><ArticleIdList><ArticleId IdType="doi">10.1017/S2040174420001373</ArticleId><ArticleId IdType="pubmed">33526164</ArticleId></ArticleIdList></Reference><Reference><Citation>Gonz&#xe1;lez-L&#xf3;pez A, Albaiceta GM, Talbot K. Newly identified precipitating factors in mechanical ventilation-induced brain damage: implications for treating ICU delirium. Expert Rev Neurother. (2014) 14:583&#x2013;8. doi:&#xa0;10.1586/14737175.2014.915743</Citation><ArticleIdList><ArticleId IdType="doi">10.1586/14737175.2014.915743</ArticleId><ArticleId IdType="pubmed">24852225</ArticleId></ArticleIdList></Reference><Reference><Citation>Stephenson J, Nutma E, van der Valk P, Amor S. Inflammation in CNS neurodegenerative diseases. Immunology. (2018) 154:204&#x2013;19. doi:&#xa0;10.1111/imm.12922</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/imm.12922</ArticleId><ArticleId IdType="pmc">PMC5980185</ArticleId><ArticleId IdType="pubmed">29513402</ArticleId></ArticleIdList></Reference><Reference><Citation>Andrade CA, Kalergis AM, Bohmwald K. Potential neurocognitive symptoms due to respiratory syncytial virus infection. Pathogens. (2021) 11:47. doi:&#xa0;10.3390/pathogens11010047</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/pathogens11010047</ArticleId><ArticleId IdType="pmc">PMC8780657</ArticleId><ArticleId IdType="pubmed">35055995</ArticleId></ArticleIdList></Reference><Reference><Citation>Espinoza JA, Bohmwald K, Cespedes PF, Gomez RS, Riquelme SA, Cortes CM, et al. . Impaired learning resulting from Respiratory Syncytial Virus infection. Proc Natl Acad Sci. (2013) 11:9112&#x2013;7. doi:&#xa0;10.1073/pnas.1217508110</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1217508110</ArticleId><ArticleId IdType="pmc">PMC3670318</ArticleId><ArticleId IdType="pubmed">23650398</ArticleId></ArticleIdList></Reference><Reference><Citation>Santos REA, da Silva MG, do Monte Silva MCB, Barbosa DAM, do Vale Gomes AL, Galindo LCM, et al. . Onset and duration of symptoms of loss of smell/taste in patients with COVID-19: A systematic review. Am J Otolaryngol. (2021) 42:102889. doi:&#xa0;10.1016/j.amjoto.2020.102889</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.amjoto.2020.102889</ArticleId><ArticleId IdType="pmc">PMC7833280</ArticleId><ArticleId IdType="pubmed">33445036</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee Y, Min P, Lee S, Kim S-W. Prevalence and duration of acute loss of smell or taste in COVID-19 patients. J Korean Med Sci. (2020) 35:e174. doi:&#xa0;10.3346/jkms.2020.35.e174</Citation><ArticleIdList><ArticleId IdType="doi">10.3346/jkms.2020.35.e174</ArticleId><ArticleId IdType="pmc">PMC7211515</ArticleId><ArticleId IdType="pubmed">32383370</ArticleId></ArticleIdList></Reference><Reference><Citation>Albaiceta GM, Brochard L, Dos Santos CC, Fern&#xe1;ndez R, Georgopoulos D, Girard T, et al. . The central nervous system during lung injury and mechanical ventilation: a narrative review. Br J Anaesth. (2021) 127:648&#x2013;59. doi:&#xa0;10.1016/J.BJA.2021.05.038</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/J.BJA.2021.05.038</ArticleId><ArticleId IdType="pubmed">34340836</ArticleId></ArticleIdList></Reference><Reference><Citation>Ferrando SJ, Dornbush R, Lynch S, Shahar S, Klepacz L, Karmen CL, et al. . Neuropsychological, medical, and psychiatric findings after recovery from acute COVID-19: A cross-sectional study. J Acad Consult Psychiatry. (2022) 63(5):474&#x2013;84. doi:&#xa0;10.1016/j.jaclp.2022.01.003</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jaclp.2022.01.003</ArticleId><ArticleId IdType="pmc">PMC8786396</ArticleId><ArticleId IdType="pubmed">35085824</ArticleId></ArticleIdList></Reference><Reference><Citation>Yeh EA, Collins A, Cohen ME, Duffner PK, Faden H. Detection of coronavirus in the central nervous system of a child with acute disseminated encephalomyelitis. Pediatrics. (2004) 113:e73&#x2013;e76. doi:&#xa0;10.1542/PEDS.113.1.E73</Citation><ArticleIdList><ArticleId IdType="doi">10.1542/PEDS.113.1.E73</ArticleId><ArticleId IdType="pubmed">14702500</ArticleId></ArticleIdList></Reference><Reference><Citation>Erickson MA, Rhea EM, Knopp RC, Banks WA. Interactions of SARS-coV-2 with the blood&#x2013;brain barrier. Int J Mol Sci. (2021) 22:2681. doi:&#xa0;10.3390/ijms22052681</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms22052681</ArticleId><ArticleId IdType="pmc">PMC7961671</ArticleId><ArticleId IdType="pubmed">33800954</ArticleId></ArticleIdList></Reference><Reference><Citation>Matschke J, L&#xfc;tgehetmann M, Hagel C, Sperhake JP, Schr&#xf6;der AS, Edler C, et al. . Neuropathology of patients with COVID-19 in Germany: a post-mortem case series. Lancet Neurol. (2020) 19:919&#x2013;29. doi:&#xa0;10.1016/S1474-4422(20)30308-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1474-4422(20)30308-2</ArticleId><ArticleId IdType="pmc">PMC7535629</ArticleId><ArticleId IdType="pubmed">33031735</ArticleId></ArticleIdList></Reference><Reference><Citation>Song E, Zhang C, Israelow B, Lu-Culligan A, Prado AV, Skriabine S, et al. . Neuroinvasion of SARS-CoV-2 in human and mouse brain. J Exp Med. (2021) 218:e20202135. doi:&#xa0;10.1084/jem.20202135</Citation><ArticleIdList><ArticleId IdType="doi">10.1084/jem.20202135</ArticleId><ArticleId IdType="pmc">PMC7808299</ArticleId><ArticleId IdType="pubmed">33433624</ArticleId></ArticleIdList></Reference><Reference><Citation>Lau K-K, Yu W-C, Chu C-M, Lau S-T, Sheng B, Yuen K-Y. Possible central nervous system infection by SARS coronavirus. Emerg Infect Dis. (2004) 10:342&#x2013;4. doi:&#xa0;10.3201/eid1002.030638</Citation><ArticleIdList><ArticleId IdType="doi">10.3201/eid1002.030638</ArticleId><ArticleId IdType="pmc">PMC3322928</ArticleId><ArticleId IdType="pubmed">15030709</ArticleId></ArticleIdList></Reference><Reference><Citation>Moriguchi T, Harii N, Goto J, Harada D, Sugawara H, Takamino J, et al. . A first case of meningitis/encephalitis associated with SARS-Coronavirus-2. Int J Infect Dis. (2020) 94:55&#x2013;8. doi:&#xa0;10.1016/j.ijid.2020.03.062</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijid.2020.03.062</ArticleId><ArticleId IdType="pmc">PMC7195378</ArticleId><ArticleId IdType="pubmed">32251791</ArticleId></ArticleIdList></Reference><Reference><Citation>Wege H, Schluesener H, Meyermann R, Barac-Latas V, Suchanek G, Lassmann H. Coronavirus infection and demyelination. Development of inflammatory lesions in Lewis rats. Adv Exp Med Biol. (1998) 440:437&#x2013;44.</Citation><ArticleIdList><ArticleId IdType="pubmed">9782312</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu GF, Perlman S. Macrophage Infiltration, but Not Apoptosis, Is Correlated with Immune-Mediated Demyelination following Murine Infection with a Neurotropic Coronavirus. J Virol. (1999) 73:8771&#x2013;80. doi:&#xa0;10.1128/JVI.73.10.8771-8780.1999</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.73.10.8771-8780.1999</ArticleId><ArticleId IdType="pmc">PMC112898</ArticleId><ArticleId IdType="pubmed">10482631</ArticleId></ArticleIdList></Reference><Reference><Citation>da Silva MM, de Lucena ASL, de S&#xe1; Leit&#xe3;o Paiva J&#xfa;nior S, De Carvalho VMF, de Oliveira PSS, da Rosa MM, et al. . Cell death mechanisms involved in cell injury caused by SARS-CoV-2. Rev Med Virol. (2022) 32:e2292. doi:&#xa0;10.1002/rmv.2292</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/rmv.2292</ArticleId><ArticleId IdType="pmc">PMC8646768</ArticleId><ArticleId IdType="pubmed">34590761</ArticleId></ArticleIdList></Reference><Reference><Citation>Charnley M, Islam S, Bindra GK, Engwirda J, Ratcliffe J, Zhou J, et al. . Neurotoxic amyloidogenic peptides in the proteome of SARS-COV2: potential implications for neurological symptoms in COVID-19. Nat Commun. (2022) 13:3387. doi:&#xa0;10.1038/s41467-022-30932-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-022-30932-1</ArticleId><ArticleId IdType="pmc">PMC9189797</ArticleId><ArticleId IdType="pubmed">35697699</ArticleId></ArticleIdList></Reference><Reference><Citation>Agosti E, Giorgianni A, D&#x2019;Amore F, Vinacci G, Balbi S, Locatelli D, et al. . Is Guillain-Barr&#xe8; syndrome triggered by SARS-CoV-2? Case report and literature review. Neurol Sci. (2021) 42:607&#x2013;12. doi:&#xa0;10.1007/s10072-020-04553-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10072-020-04553-9</ArticleId><ArticleId IdType="pmc">PMC7343406</ArticleId><ArticleId IdType="pubmed">32643136</ArticleId></ArticleIdList></Reference><Reference><Citation>Bigaut K, Mallaret M, Baloglu S, Nemoz B, Morand P, Baicry F, et al. . Guillain-Barr&#xe9; syndrome related to SARS-CoV-2 infection. Neurol Neuroimmunol Neuroinflamm. (2020) 7:1351&#x2013;1354. doi:&#xa0;10.1212/NXI.0000000000000785</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/NXI.0000000000000785</ArticleId><ArticleId IdType="pmc">PMC7286648</ArticleId><ArticleId IdType="pubmed">32461235</ArticleId></ArticleIdList></Reference><Reference><Citation>Ottaviani D, Boso F, Tranquillini E, Gapeni I, Pedrotti G, Cozzio S, et al. . Early Guillain-Barr&#xe9; syndrome in coronavirus disease 2019 (COVID-19): a case report from an Italian COVID-hospital. Neurol Sci. (2020) 41:1351&#x2013;4. doi:&#xa0;10.1007/s10072-020-04449-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10072-020-04449-8</ArticleId><ArticleId IdType="pmc">PMC7216127</ArticleId><ArticleId IdType="pubmed">32399950</ArticleId></ArticleIdList></Reference><Reference><Citation>Lucchese G, Fl&#xf6;el A. SARS-CoV-2 and Guillain-Barr&#xe9; syndrome: molecular mimicry with human heat shock proteins as potential pathogenic mechanism. Cell Stress Chaperones. (2020) 25:731&#x2013;5. doi:&#xa0;10.1007/s12192-020-01145-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12192-020-01145-6</ArticleId><ArticleId IdType="pmc">PMC7387880</ArticleId><ArticleId IdType="pubmed">32729001</ArticleId></ArticleIdList></Reference><Reference><Citation>Yuki N, Hartung H-P. Guillain-barr&#xe9; syndrome. N Engl J Med. (2012) 366:2294&#x2013;304. doi:&#xa0;10.1056/NEJMra1114525</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMra1114525</ArticleId><ArticleId IdType="pubmed">22694000</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee J-G, Huang W, Lee H, van de Leemput J, Kane MA, Han Z. Characterization of SARS-CoV-2 proteins reveals Orf6 pathogenicity, subcellular localization, host interactions and attenuation by Selinexor. Cell Biosci. (2021) 11:58. doi:&#xa0;10.1186/s13578-021-00568-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13578-021-00568-7</ArticleId><ArticleId IdType="pmc">PMC7993076</ArticleId><ArticleId IdType="pubmed">33766124</ArticleId></ArticleIdList></Reference><Reference><Citation>Gy&#xf6;ngy&#xf6;si M, Alcaide P, Asselbergs FW, Brundel BJJM, Camici GG, Da Costa Martins P, et al. . Long COVID and the cardiovascular system-elucidating causes and cellular mechanisms in order to develop targeted diagnostic and therapeutic strategies: a joint Scientific Statement of the ESC Working Groups on Cellular Biology of the Heart and Myocardial and Pericardial Diseases. Cardiovasc Res. (2023) 119:336&#x2013;56. doi:&#xa0;10.1093/CVR/CVAC115</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/CVR/CVAC115</ArticleId><ArticleId IdType="pmc">PMC9384470</ArticleId><ArticleId IdType="pubmed">35875883</ArticleId></ArticleIdList></Reference><Reference><Citation>Xie Y, Xu E, Bowe B, Al-Aly Z. Long-term cardiovascular outcomes of COVID-19. Nat Med. (2022) 28:583&#x2013;90. doi:&#xa0;10.1038/s41591-022-01689-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-022-01689-3</ArticleId><ArticleId IdType="pmc">PMC8938267</ArticleId><ArticleId IdType="pubmed">35132265</ArticleId></ArticleIdList></Reference><Reference><Citation>Azevedo RB, Botelho BG, de Hollanda JVG, Ferreira LVL, de Andrade LZJ, Oei SSML, et al. . Covid-19 and the cardiovascular system: a comprehensive review. J Hum Hypertens. (2021) 35:4&#x2013;11. doi:&#xa0;10.1038/s41371-020-0387-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41371-020-0387-4</ArticleId><ArticleId IdType="pmc">PMC7384729</ArticleId><ArticleId IdType="pubmed">32719447</ArticleId></ArticleIdList></Reference><Reference><Citation>Tajbakhsh A, Hayat SMG, Taghizadeh H, Akbari A, inabadi M, Savardashtaki A, et al. . COVID-19 and cardiac injury: clinical manifestations, biomarkers, mechanisms, diagnosis, treatment, and follow up. Expert Rev Anti Infect Ther. (2021) 19:345&#x2013;57. doi:&#xa0;10.1080/14787210.2020.1822737</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/14787210.2020.1822737</ArticleId><ArticleId IdType="pubmed">32921216</ArticleId></ArticleIdList></Reference><Reference><Citation>Zou F, Qian Z, Wang Y, Zhao Y, Bai J. Cardiac injury and COVID-19: A systematic review and meta-analysis. CJC Open. (2020) 2:386&#x2013;94. doi:&#xa0;10.1016/j.cjco.2020.06.010</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cjco.2020.06.010</ArticleId><ArticleId IdType="pmc">PMC7308771</ArticleId><ArticleId IdType="pubmed">32838255</ArticleId></ArticleIdList></Reference><Reference><Citation>Puntmann VO, Carerj ML, Wieters I, Fahim M, Arendt C, Hoffmann J, et al. . Outcomes of cardiovascular magnetic resonance imaging in patients recently recovered from coronavirus disease 2019 (COVID-19). JAMA Cardiol. (2020) 5:1265. doi:&#xa0;10.1001/jamacardio.2020.3557</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamacardio.2020.3557</ArticleId><ArticleId IdType="pmc">PMC7385689</ArticleId><ArticleId IdType="pubmed">32730619</ArticleId></ArticleIdList></Reference><Reference><Citation>Lindner D, Fitzek A, Br&#xe4;uninger H, Aleshcheva G, Edler C, Meissner K, et al. . Association of cardiac infection with SARS-coV-2 in confirmed COVID-19 autopsy cases. JAMA Cardiol. (2020) 5:1281. doi:&#xa0;10.1001/jamacardio.2020.3551</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamacardio.2020.3551</ArticleId><ArticleId IdType="pmc">PMC7385672</ArticleId><ArticleId IdType="pubmed">32730555</ArticleId></ArticleIdList></Reference><Reference><Citation>Bailey AL, Dmytrenko O, Greenberg L, Bredemeyer AL, Ma P, Liu J, et al. . SARS-coV-2 infects human engineered heart tissues and models COVID-19 myocarditis. JACC Basic to Transl Sci. (2021) 6:331&#x2013;45. doi:&#xa0;10.1016/j.jacbts.2021.01.002</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jacbts.2021.01.002</ArticleId><ArticleId IdType="pmc">PMC7909907</ArticleId><ArticleId IdType="pubmed">33681537</ArticleId></ArticleIdList></Reference><Reference><Citation>Khismatullin RR, Ponomareva AA, Nagaswami C, Ivaeva RA, Montone KT, Weisel JW, et al. . Pathology of lung-specific thrombosis and inflammation in COVID-19. J Thromb Haemost. (2021) 19:3062&#x2013;72. doi:&#xa0;10.1111/jth.15532</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jth.15532</ArticleId><ArticleId IdType="pmc">PMC8646730</ArticleId><ArticleId IdType="pubmed">34538029</ArticleId></ArticleIdList></Reference><Reference><Citation>Inciardi RM, Lupi L, Zaccone G, Italia L, Raffo M, Tomasoni D, et al. . Cardiac involvement in a patient with coronavirus disease 2019 (COVID-19). JAMA Cardiol. (2020) 5:819. doi:&#xa0;10.1001/jamacardio.2020.1096</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamacardio.2020.1096</ArticleId><ArticleId IdType="pmc">PMC7364333</ArticleId><ArticleId IdType="pubmed">32219357</ArticleId></ArticleIdList></Reference><Reference><Citation>Shi S, Qin M, Shen B, Cai Y, Liu T, Yang F, et al. . Association of cardiac injury with mortality in hospitalized patients with COVID-19 in wuhan, China. JAMA Cardiol. (2020) 5:802. doi:&#xa0;10.1001/jamacardio.2020.0950</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamacardio.2020.0950</ArticleId><ArticleId IdType="pmc">PMC7097841</ArticleId><ArticleId IdType="pubmed">32211816</ArticleId></ArticleIdList></Reference><Reference><Citation>Breitbart P, Koch A, Schmidt M, Magedanz A, Lindhoff-Last E, Voigtl&#xe4;nder T, et al. . Clinical and cardiac magnetic resonance findings in post-COVID patients referred for suspected myocarditis. Clin Res Cardiol. (2021) 110:1832&#x2013;40. doi:&#xa0;10.1007/s00392-021-01929-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00392-021-01929-5</ArticleId><ArticleId IdType="pmc">PMC8390029</ArticleId><ArticleId IdType="pubmed">34448040</ArticleId></ArticleIdList></Reference><Reference><Citation>Druzak S, Iffrig E, Roberts BR, Zhang T, Fibben KS, Sakurai Y, et al. . Multiplatform analyses reveal distinct drivers of systemic pathogenesis in adult versus pediatric severe acute COVID-19. Nat Commun. (2023) 14:1638. doi:&#xa0;10.1038/S41467-023-37269-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/S41467-023-37269-3</ArticleId><ArticleId IdType="pmc">PMC10073144</ArticleId><ArticleId IdType="pubmed">37015925</ArticleId></ArticleIdList></Reference><Reference><Citation>Vassiliou AG, Vrettou CS, Keskinidou C, Dimopoulou I, Kotanidou A, Orfanos SE. Endotheliopathy in acute COVID-19 and long COVID. Int J Mol Sci. (2023) 24:8237. doi:&#xa0;10.3390/IJMS24098237</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/IJMS24098237</ArticleId><ArticleId IdType="pmc">PMC10179170</ArticleId><ArticleId IdType="pubmed">37175942</ArticleId></ArticleIdList></Reference><Reference><Citation>Neurath MF, Uberla K, Ng SC. Gut as viral reservoir: lessons from gut viromes, HIV and COVID-19. Gut. (2021) 70:1605&#x2013;8. doi:&#xa0;10.1136/GUTJNL-2021-324622</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/GUTJNL-2021-324622</ArticleId><ArticleId IdType="pubmed">33903146</ArticleId></ArticleIdList></Reference><Reference><Citation>Ccl C, Goh D, Lim X. Correction: Residual SARS-CoV-2 viral antigens detected in GI and hepatic tissues from five recovered patients with COVID-19. Gut. (2022) 71:e9&#x2013;9. doi:&#xa0;10.1136/gutjnl-2021-324280corr1</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/gutjnl-2021-324280corr1</ArticleId><ArticleId IdType="pubmed">35798364</ArticleId></ArticleIdList></Reference><Reference><Citation>Buonsenso D, Martino L, Morello R, Mariani F, Fearnley K, Valentini P. Viral persistence in children infected with SARS-CoV-2: current evidence and future research strategies. Lancet Microbe. (2023) 4:e745&#x2013;56. doi:&#xa0;10.1016/S2666-5247(23)00115-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2666-5247(23)00115-5</ArticleId><ArticleId IdType="pmc">PMC10292824</ArticleId><ArticleId IdType="pubmed">37385286</ArticleId></ArticleIdList></Reference><Reference><Citation>Varga Z, Flammer AJ, Steiger P, Haberecker M, Andermatt R, Zinkernagel AS, et al. . Endothelial cell infection and endotheliitis in COVID-19. The Lancet. (2020) 395:1417&#x2013;8. doi:&#xa0;10.1016/S0140-6736(20)30937-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(20)30937-5</ArticleId><ArticleId IdType="pmc">PMC7172722</ArticleId><ArticleId IdType="pubmed">32325026</ArticleId></ArticleIdList></Reference><Reference><Citation>Stein SR, Ramelli SC, Grazioli A, Chung JYJE, Singh M, Yinda CK, et al. . SARS-CoV-2 infection and persistence in the human body and brain at autopsy. Nature. (2022) 612:758&#x2013;63. doi:&#xa0;10.1038/s41586-022-05542-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-022-05542-y</ArticleId><ArticleId IdType="pmc">PMC9749650</ArticleId><ArticleId IdType="pubmed">36517603</ArticleId></ArticleIdList></Reference><Reference><Citation>Ninan S, Thompson P, Gershon T, Ford N, Mills W, Jewells V, et al. . Fatal pediatric COVID-19 case with seizures and fulminant cerebral edema. Child Neurol Open. (2021) 8:2329048X2110225. doi:&#xa0;10.1177/2329048X211022532</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/2329048X211022532</ArticleId><ArticleId IdType="pmc">PMC8207268</ArticleId><ArticleId IdType="pubmed">34179214</ArticleId></ArticleIdList></Reference><Reference><Citation>Arostegui D, Castro K, Schwarz S, Vaidy K, Rabinowitz S, Wallach T. Persistent SARS-coV-2 nucleocapsid protein presence in the intestinal epithelium of a pediatric patient 3 months after acute infection. JPGN Rep. (2021) 3:e152. doi:&#xa0;10.1097/PG9.0000000000000152</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/PG9.0000000000000152</ArticleId><ArticleId IdType="pmc">PMC10158423</ArticleId><ArticleId IdType="pubmed">37168753</ArticleId></ArticleIdList></Reference><Reference><Citation>Sigal GB, Novak T, Mathew A, Chou J, Zhang Y, Manjula N, et al. . Measurement of severe acute respiratory syndrome coronavirus 2 antigens in plasma of pediatric patients with acute coronavirus disease 2019 or multisystem inflammatory syndrome in children using an ultrasensitive and quantitative immunoassay. Clin Infect Dis. (2022) 75:1351&#x2013;8. doi:&#xa0;10.1093/CID/CIAC160</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/CID/CIAC160</ArticleId><ArticleId IdType="pmc">PMC8903440</ArticleId><ArticleId IdType="pubmed">35213684</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu Q, Milanez-Almeida P, Martins AJ, Radtke AJ, Hoehn KB, Oguz C, et al. . Adaptive immune responses to SARS-CoV-2 persist in the pharyngeal lymphoid tissue of children. Nat Immunol. (2023) 24:186&#x2013;99. doi:&#xa0;10.1038/s41590-022-01367-z</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41590-022-01367-z</ArticleId><ArticleId IdType="pmc">PMC10777159</ArticleId><ArticleId IdType="pubmed">36536106</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen B, Julg B, Mohandas S, Bradfute SB. Viral persistence, reactivation, and mechanisms of long COVID. Elife. (2023) 12:e86015. doi:&#xa0;10.7554/ELIFE.86015</Citation><ArticleIdList><ArticleId IdType="doi">10.7554/ELIFE.86015</ArticleId><ArticleId IdType="pmc">PMC10159620</ArticleId><ArticleId IdType="pubmed">37140960</ArticleId></ArticleIdList></Reference><Reference><Citation>Taweevisit M, Chindamporn A, Sujjavorakul K, Samransamruajkit R, Thorner PS. Multisystem inflammatory syndrome in children (MIS-C) showing disseminated aspergillosis, cytomegalovirus reactivation and persistent SARS-COV-2: Case report with autopsy review. Pathol Res Pract. (2022) 238:154106. doi:&#xa0;10.1016/J.PRP.2022.154106</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/J.PRP.2022.154106</ArticleId><ArticleId IdType="pmc">PMC9443656</ArticleId><ArticleId IdType="pubmed">36087417</ArticleId></ArticleIdList></Reference><Reference><Citation>Turner S, Khan MA, Putrino D, Woodcock A, Kell DB, Pretorius E. Long COVID: pathophysiological factors and abnormalities of coagulation. Trends Endocrinol Metab. (2023) 34:321&#x2013;44. doi:&#xa0;10.1016/J.TEM.2023.03.002</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/J.TEM.2023.03.002</ArticleId><ArticleId IdType="pmc">PMC10113134</ArticleId><ArticleId IdType="pubmed">37080828</ArticleId></ArticleIdList></Reference><Reference><Citation>Borowiec BM, Volponi AA, Mozdziak P, Kempisty B, Dyszkiewicz-Konwi&#x144;ska M. Small extracellular vesicles and COVID19-using the &#x201c;Trojan horse&#x201d; to tackle the giant. Cells. (2021) 10:3383. doi:&#xa0;10.3390/CELLS10123383</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/CELLS10123383</ArticleId><ArticleId IdType="pmc">PMC8699232</ArticleId><ArticleId IdType="pubmed">34943891</ArticleId></ArticleIdList></Reference><Reference><Citation>Barberis E, Vanella VV, Falasca M, Caneapero V, Cappellano G, Raineri D, et al. . Circulating exosomes are strongly involved in SARS-coV-2 infection. Front Mol Biosci. (2021) 8:632290. doi:&#xa0;10.3389/FMOLB.2021.632290</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/FMOLB.2021.632290</ArticleId><ArticleId IdType="pmc">PMC7937875</ArticleId><ArticleId IdType="pubmed">33693030</ArticleId></ArticleIdList></Reference><Reference><Citation>Ali RA, Wuescher LM, Worth RG. Platelets: essential components of the immune system. Curr Trends Immunol. (2015) 16:65.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5096834</ArticleId><ArticleId IdType="pubmed">27818580</ArticleId></ArticleIdList></Reference><Reference><Citation>Pretorius E, Vlok M, Venter C, Bezuidenhout JA, Laubscher GJ, Steenkamp J, et al. . Persistent clotting protein pathology in Long COVID/Post-Acute Sequelae of COVID-19 (PASC) is accompanied by increased levels of antiplasmin. Cardiovasc Diabetol. (2021) 20:172. doi:&#xa0;10.1186/S12933-021-01359-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/S12933-021-01359-7</ArticleId><ArticleId IdType="pmc">PMC8381139</ArticleId><ArticleId IdType="pubmed">34425843</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang C, Yu C, Jing H, Wu X, Novakovic VA, Xie R, et al. . Long COVID: the nature of thrombotic sequelae determines the necessity of early anticoagulation. Front Cell Infect Microbiol. (2022) 12:861703. doi:&#xa0;10.3389/FCIMB.2022.861703</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/FCIMB.2022.861703</ArticleId><ArticleId IdType="pmc">PMC9016198</ArticleId><ArticleId IdType="pubmed">35449732</ArticleId></ArticleIdList></Reference><Reference><Citation>Ackermann M, Verleden SE, Kuehnel M, Haverich A, Welte T, Laenger F, et al. . Pulmonary vascular endothelialitis, thrombosis, and angiogenesis in covid-19. N Engl J Med. (2020) 383:120&#x2013;8. doi:&#xa0;10.1056/NEJMoa2015432</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa2015432</ArticleId><ArticleId IdType="pmc">PMC7412750</ArticleId><ArticleId IdType="pubmed">32437596</ArticleId></ArticleIdList></Reference><Reference><Citation>Phetsouphanh C, Darley DR, Wilson DB, Howe A, Munier CML, Patel SK, et al. . Immunological dysfunction persists for 8 months following initial mild-to-moderate SARS-CoV-2 infection. Nat Immunol. (2022) 23:210&#x2013;6. doi:&#xa0;10.1038/s41590-021-01113-x</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41590-021-01113-x</ArticleId><ArticleId IdType="pubmed">35027728</ArticleId></ArticleIdList></Reference><Reference><Citation>Clausen TM, Sandoval DR, Spliid CB, Pihl J, Perrett HR, Painter CD, et al. . SARS-coV-2 infection depends on cellular heparan sulfate and ACE2. Cell. (2020) 183:1043&#x2013;1057.e15. doi:&#xa0;10.1016/j.cell.2020.09.033</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2020.09.033</ArticleId><ArticleId IdType="pmc">PMC7489987</ArticleId><ArticleId IdType="pubmed">32970989</ArticleId></ArticleIdList></Reference><Reference><Citation>Kotagiri P, Mescia F, Hanson AL, Turner L, Bergamaschi L, Pe&#xf1;alver A, et al. . The impact of hypoxia on B cells in COVID-19. EBioMedicine. (2022) 77:103878. doi:&#xa0;10.1016/J.EBIOM.2022.103878</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/J.EBIOM.2022.103878</ArticleId><ArticleId IdType="pmc">PMC8856886</ArticleId><ArticleId IdType="pubmed">35189575</ArticleId></ArticleIdList></Reference><Reference><Citation>Carvalho-Schneider C, Laurent E, Lemaignen A, Beaufils E, Bourbao-Tournois C, Laribi S, et al. . Follow-up of adults with noncritical COVID-19 two months after symptom onset. Clin Microbiol Infect. (2021) 27:258&#x2013;63. doi:&#xa0;10.1016/j.cmi.2020.09.052</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cmi.2020.09.052</ArticleId><ArticleId IdType="pmc">PMC7534895</ArticleId><ArticleId IdType="pubmed">33031948</ArticleId></ArticleIdList></Reference><Reference><Citation>D&#x2019;Cruz RF, Waller MD, Perrin F, Periselneris J, Norton S, Smith L-J, et al. . Chest radiography is a poor predictor of respiratory symptoms and functional impairment in survivors of severe COVID-19 pneumonia. ERJ Open Res. (2021) 7:655&#x2013;2020. doi:&#xa0;10.1183/23120541.00655-2020</Citation><ArticleIdList><ArticleId IdType="doi">10.1183/23120541.00655-2020</ArticleId><ArticleId IdType="pmc">PMC7585700</ArticleId><ArticleId IdType="pubmed">33575312</ArticleId></ArticleIdList></Reference><Reference><Citation>Tomasoni D, Bai F, Castoldi R, Barbanotti D, Falcinella C, Mul&#xe8; G, et al. . Anxiety and depression symptoms after virological clearance of COVID-19: A cross-sectional study in Milan, Italy. J Med Virol. (2021) 93:1175&#x2013;9. doi:&#xa0;10.1002/jmv.26459</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.26459</ArticleId><ArticleId IdType="pmc">PMC7461061</ArticleId><ArticleId IdType="pubmed">32841387</ArticleId></ArticleIdList></Reference><Reference><Citation>Wong SH, Lui RNS, Sung JJY. Covid-19 and the digestive system. J Gastroenterol Hepatol. (2020) 35:744&#x2013;8. doi:&#xa0;10.1111/jgh.15047</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jgh.15047</ArticleId><ArticleId IdType="pubmed">32215956</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao Y, Shang Y, Song W, Li Q, Xie H, Xu Q, et al. . Follow-up study of the pulmonary function and related physiological characteristics of COVID-19 survivors three months after recovery. EClinicalMedicine. (2020) 25:100463. doi:&#xa0;10.1016/j.eclinm.2020.100463</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.eclinm.2020.100463</ArticleId><ArticleId IdType="pmc">PMC7361108</ArticleId><ArticleId IdType="pubmed">32838236</ArticleId></ArticleIdList></Reference><Reference><Citation>Xiao F, Tang M, Zheng X, Liu Y, Li X, Shan H. Evidence for gastrointestinal infection of SARS-coV-2. Gastroenterology. (2020) 158:1831&#x2013;1833.e3. doi:&#xa0;10.1053/j.gastro.2020.02.055</Citation><ArticleIdList><ArticleId IdType="doi">10.1053/j.gastro.2020.02.055</ArticleId><ArticleId IdType="pmc">PMC7130181</ArticleId><ArticleId IdType="pubmed">32142773</ArticleId></ArticleIdList></Reference><Reference><Citation>Natarajan A, Zlitni S, Brooks EF, Vance SE, Dahlen A, Hedlin H, et al. . Gastrointestinal symptoms and fecal shedding of SARS-CoV-2 RNA suggest prolonged gastrointestinal infection. Med (New York NY). (2022) 3:371&#x2013;387.e9. doi:&#xa0;10.1016/J.MEDJ.2022.04.001</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/J.MEDJ.2022.04.001</ArticleId><ArticleId IdType="pmc">PMC9005383</ArticleId><ArticleId IdType="pubmed">35434682</ArticleId></ArticleIdList></Reference><Reference><Citation>Hoffmann M, Kleine-Weber H, Schroeder S, Kr&#xfc;ger N, Herrler T, Erichsen S, et al. . SARS-coV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor. Cell. (2020) 181:271&#x2013;280.e8. doi:&#xa0;10.1016/j.cell.2020.02.052</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2020.02.052</ArticleId><ArticleId IdType="pmc">PMC7102627</ArticleId><ArticleId IdType="pubmed">32142651</ArticleId></ArticleIdList></Reference><Reference><Citation>Jackson CB, Farzan M, Chen B, Choe H. Mechanisms of SARS-CoV-2 entry into cells. Nat Rev Mol Cell Biol. (2022) 23:3&#x2013;20. doi:&#xa0;10.1038/s41580-021-00418-x</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41580-021-00418-x</ArticleId><ArticleId IdType="pmc">PMC8491763</ArticleId><ArticleId IdType="pubmed">34611326</ArticleId></ArticleIdList></Reference><Reference><Citation>Lupala CS, Ye Y, Chen H, Su X-D, Liu H. Mutations on RBD of SARS-CoV-2 Omicron variant result in stronger binding to human ACE2 receptor. Biochem Biophys Res Commun. (2022) 590:34&#x2013;41. doi:&#xa0;10.1016/j.bbrc.2021.12.079</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbrc.2021.12.079</ArticleId><ArticleId IdType="pmc">PMC8702632</ArticleId><ArticleId IdType="pubmed">34968782</ArticleId></ArticleIdList></Reference><Reference><Citation>Winkler ES, Chen RE, Alam F, Yildiz S, Case JB, Uccellini MB, et al. . SARS-coV-2 causes lung infection without severe disease in human ACE2 knock-in mice. J Virol. (2022) 96:e0151121. doi:&#xa0;10.1128/JVI.01511-21</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.01511-21</ArticleId><ArticleId IdType="pmc">PMC8754206</ArticleId><ArticleId IdType="pubmed">34668780</ArticleId></ArticleIdList></Reference><Reference><Citation>Hung IFN, Cheng VCC, Wu AKL, Tang BSF, Chan KH, Chu CM, et al. . Viral loads in clinical specimens and SARS manifestations. Emerg Infect Dis. (2004) 10:1550&#x2013;7. doi:&#xa0;10.3201/eid1009.040058</Citation><ArticleIdList><ArticleId IdType="doi">10.3201/eid1009.040058</ArticleId><ArticleId IdType="pmc">PMC3320271</ArticleId><ArticleId IdType="pubmed">15498155</ArticleId></ArticleIdList></Reference><Reference><Citation>Leung WK, To K, Chan PKS, Chan HLY, Wu AKL, Lee N, et al. . Enteric involvement of severe acute respiratory syndrome-associated coronavirus infection. Gastroenterology. (2003) 125:as0016508503012150. doi:&#xa0;10.1016/S0016-5085(03)01215-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0016-5085(03)01215-0</ArticleId><ArticleId IdType="pmc">PMC7126982</ArticleId><ArticleId IdType="pubmed">14517783</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou J, Li C, Zhao G, Chu H, Wang D, Yan HH-N, et al. . Human intestinal tract serves as an alternative infection route for Middle East respiratory syndrome coronavirus. Sci Adv. (2017) 3:eaao4966. doi:&#xa0;10.1126/sciadv.aao4966</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/sciadv.aao4966</ArticleId><ArticleId IdType="pmc">PMC5687858</ArticleId><ArticleId IdType="pubmed">29152574</ArticleId></ArticleIdList></Reference><Reference><Citation>Lu R, Zhao X, Li J, Niu P, Yang B, Wu H, et al. . Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding. Lancet. (2020) 395:565&#x2013;74. doi:&#xa0;10.1016/S0140-6736(20)30251-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(20)30251-8</ArticleId><ArticleId IdType="pmc">PMC7159086</ArticleId><ArticleId IdType="pubmed">32007145</ArticleId></ArticleIdList></Reference><Reference><Citation>Gaebler C, Wang Z, Lorenzi JCC, Muecksch F, Finkin S, Tokuyama M, et al. . Evolution of antibody immunity to SARS-CoV-2. Nat. (2021) 591:639&#x2013;44. doi:&#xa0;10.1038/s41586-021-03207-w</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-021-03207-w</ArticleId><ArticleId IdType="pmc">PMC8221082</ArticleId><ArticleId IdType="pubmed">33461210</ArticleId></ArticleIdList></Reference><Reference><Citation>Morone G, Palomba A, Iosa M, Caporaso T, De Angelis D, Venturiero V, et al. . Incidence and persistence of viral shedding in COVID-19 post-acute patients with negativized pharyngeal swab: A systematic review. Front Med. (2020) 7:562. doi:&#xa0;10.3389/FMED.2020.00562</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/FMED.2020.00562</ArticleId><ArticleId IdType="pmc">PMC7483760</ArticleId><ArticleId IdType="pubmed">32984389</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu Y, Guo C, Tang L, Hong Z, Zhou J, Dong X, et al. . Prolonged presence of SARS-CoV-2 viral RNA in faecal samples. Lancet Gastroenterol Hepatol. (2020) 5:434&#x2013;5. doi:&#xa0;10.1016/S2468-1253(20)30083-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2468-1253(20)30083-2</ArticleId><ArticleId IdType="pmc">PMC7158584</ArticleId><ArticleId IdType="pubmed">32199469</ArticleId></ArticleIdList></Reference><Reference><Citation>Sencio V, MaChado MG, Trottein F. The lung-gut axis during viral respiratory infections: the impact of gut dysbiosis on secondary disease outcomes. Mucosal Immunol. (2021) 14:296&#x2013;304. doi:&#xa0;10.1038/S41385-020-00361-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/S41385-020-00361-8</ArticleId><ArticleId IdType="pmc">PMC7835650</ArticleId><ArticleId IdType="pubmed">33500564</ArticleId></ArticleIdList></Reference><Reference><Citation>Neag MA, Vulturar DM, Gherman D, Burlacu CC, Todea DA, Buzoianu AD. Gastrointestinal microbiota: A predictor of COVID-19 severity? World J Gastroenterol. (2022) 28:6328. doi:&#xa0;10.3748/WJG.V28.I45.6328</Citation><ArticleIdList><ArticleId IdType="doi">10.3748/WJG.V28.I45.6328</ArticleId><ArticleId IdType="pmc">PMC9753053</ArticleId><ArticleId IdType="pubmed">36533107</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang H, Shao B, Dang Q, Chen Z, Zhou Q, Luo H, et al. . Pathogenesis and mechanism of gastrointestinal infection with COVID-19. Front Immunol. (2021) 12:674074. doi:&#xa0;10.3389/FIMMU.2021.674074</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/FIMMU.2021.674074</ArticleId><ArticleId IdType="pmc">PMC8631495</ArticleId><ArticleId IdType="pubmed">34858386</ArticleId></ArticleIdList></Reference><Reference><Citation>Oliva A, Miele MC, Di Timoteo F, De Angelis M, Mauro V, Aronica R, et al. . Persistent systemic microbial translocation and intestinal damage during coronavirus disease-19. Front Immunol. (2021) 12:708149. doi:&#xa0;10.3389/fimmu.2021.708149.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2021.708149</ArticleId><ArticleId IdType="pmc">PMC8316921</ArticleId><ArticleId IdType="pubmed">34335624</ArticleId></ArticleIdList></Reference><Reference><Citation>George V, Harrison L, Roach M, Li XD, Tierney C, Fischl MA, et al. . Associations of plasma cytokine and microbial translocation biomarkers with immune reconstitution inflammatory syndrome. J Infect Dis. (2017) 216:1159&#x2013;63. doi:&#xa0;10.1093/INFDIS/JIX460</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/INFDIS/JIX460</ArticleId><ArticleId IdType="pmc">PMC5853564</ArticleId><ArticleId IdType="pubmed">29040604</ArticleId></ArticleIdList></Reference><Reference><Citation>Giron LB, Dweep H, Yin X, Wang H, Damra M, Goldman AR, et al. . Plasma markers of disrupted gut permeability in severe COVID-19 patients. Front Immunol. (2021) 12:686240. doi:&#xa0;10.3389/fimmu.2021.779064</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2021.779064</ArticleId><ArticleId IdType="pmc">PMC8219958</ArticleId><ArticleId IdType="pubmed">34177935</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu D, Yang XO. TH17 responses in cytokine storm of COVID-19: An emerging target of JAK2 inhibitor Fedratinib. J Microbiol Immunol Infect. (2020) 53:368&#x2013;70. doi:&#xa0;10.1016/J.JMII.2020.03.005</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/J.JMII.2020.03.005</ArticleId><ArticleId IdType="pmc">PMC7156211</ArticleId><ArticleId IdType="pubmed">32205092</ArticleId></ArticleIdList></Reference><Reference><Citation>Beliz&#xe1;rio JE, Faintuch J, Garay-Malpartida M. Gut microbiome dysbiosis and immunometabolism: new frontiers for treatment of metabolic diseases. Mediators Inflammation. (2018) 2018:2037838. doi:&#xa0;10.1155/2018/2037838</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2018/2037838</ArticleId><ArticleId IdType="pmc">PMC6304917</ArticleId><ArticleId IdType="pubmed">30622429</ArticleId></ArticleIdList></Reference><Reference><Citation>Beliz&#xe1;rio JE, Faintuch J. Microbiome and gut dysbiosis. Exp Suppl. (2018) 109:459&#x2013;76. doi:&#xa0;10.1007/978-3-319-74932-7_13</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/978-3-319-74932-7_13</ArticleId><ArticleId IdType="pubmed">30535609</ArticleId></ArticleIdList></Reference><Reference><Citation>Dickson RP, Schultz MJ, van der Poll T, Schouten LR, Falkowski NR, Luth JE, et al. . Lung microbiota predict clinical outcomes in critically ill patients. Am J Respir Crit Care Med. (2020) 201:555&#x2013;63. doi:&#xa0;10.1164/rccm.201907-1487OC</Citation><ArticleIdList><ArticleId IdType="doi">10.1164/rccm.201907-1487OC</ArticleId><ArticleId IdType="pmc">PMC7047465</ArticleId><ArticleId IdType="pubmed">31973575</ArticleId></ArticleIdList></Reference><Reference><Citation>Gu S, Chen Y, Wu Z, Chen Y, Gao H, Lv L, et al. . Alterations of the gut microbiota in patients with coronavirus disease 2019 or H1N1 influenza. Clin Infect Dis. (2020) 71:2669&#x2013;78. doi:&#xa0;10.1093/CID/CIAA709</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/CID/CIAA709</ArticleId><ArticleId IdType="pmc">PMC7314193</ArticleId><ArticleId IdType="pubmed">32497191</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu R, Lu R, Zhang T, Wu Q, Cai W, Han X, et al. . Temporal association between human upper respiratory and gut bacterial microbiomes during the course of COVID-19 in adults. Commun Biol. (2021) 4:1&#x2013;11. doi:&#xa0;10.1038/s42003-021-01796-w</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s42003-021-01796-w</ArticleId><ArticleId IdType="pmc">PMC7893062</ArticleId><ArticleId IdType="pubmed">33603076</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen Y, Gu S, Chen Y, Lu H, Shi D, Guo J, et al. . Six-month follow-up of gut microbiota richness in patients with COVID-19. Gut. (2022) 71:222&#x2013;5. doi:&#xa0;10.1136/GUTJNL-2021-324090</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/GUTJNL-2021-324090</ArticleId><ArticleId IdType="pmc">PMC8666823</ArticleId><ArticleId IdType="pubmed">33833065</ArticleId></ArticleIdList></Reference><Reference><Citation>Irum N, Afzal T, Faraz MH, Aslam Z, Rasheed F. The role of gut microbiota in depression: an analysis of the gut-brain axis. Front Behav Neurosci. (2023) 17:1185522/BIBTEX. doi:&#xa0;10.3389/fnbeh.2023.1185522</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnbeh.2023.1185522</ArticleId><ArticleId IdType="pmc">PMC10272349</ArticleId><ArticleId IdType="pubmed">37333479</ArticleId></ArticleIdList></Reference><Reference><Citation>Brogna C, Brogna B, Bisaccia DR, Lauritano F, Marino G, Montano L, et al. . Could SARS-coV-2 have bacteriophage behavior or induce the activity of other bacteriophages? Vaccines. (2022) 10:708. doi:&#xa0;10.3390/VACCINES10050708</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/VACCINES10050708</ArticleId><ArticleId IdType="pmc">PMC9143435</ArticleId><ArticleId IdType="pubmed">35632464</ArticleId></ArticleIdList></Reference><Reference><Citation>Palevsky PM. Endpoints for clinical trials of acute kidney injury. Nephron. (2018) 140:111&#x2013;5. doi:&#xa0;10.1159/000493203</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000493203</ArticleId><ArticleId IdType="pubmed">30205392</ArticleId></ArticleIdList></Reference><Reference><Citation>Yende S, Parikh CR. Long COVID and kidney disease. Nat Rev Nephrol. (2021) 17:792&#x2013;3. doi:&#xa0;10.1038/s41581-021-00487-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41581-021-00487-3</ArticleId><ArticleId IdType="pmc">PMC8427150</ArticleId><ArticleId IdType="pubmed">34504319</ArticleId></ArticleIdList></Reference><Reference><Citation>Pei G, Zhang Z, Peng J, Liu L, Zhang C, Yu C, et al. . Renal involvement and early prognosis in patients with COVID-19 pneumonia. J Am Soc Nephrol. (2020) 31:1157&#x2013;65. doi:&#xa0;10.1681/ASN.2020030276</Citation><ArticleIdList><ArticleId IdType="doi">10.1681/ASN.2020030276</ArticleId><ArticleId IdType="pmc">PMC7269350</ArticleId><ArticleId IdType="pubmed">32345702</ArticleId></ArticleIdList></Reference><Reference><Citation>Davis HE, McCorkell L, Vogel JM, Topol EJ. Long COVID: major findings, mechanisms and recommendations. Nat Rev Microbiol. (2023) 21:133&#x2013;46. doi:&#xa0;10.1038/s41579-022-00846-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41579-022-00846-2</ArticleId><ArticleId IdType="pmc">PMC9839201</ArticleId><ArticleId IdType="pubmed">36639608</ArticleId></ArticleIdList></Reference><Reference><Citation>Kellum JA, Olivier van Till JW, Mulligan G. Targeting acute kidney injury in COVID-19. Nephrol Dial Transplant. (2020) 35:1652&#x2013;62. doi:&#xa0;10.1093/NDT/GFAA231</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/NDT/GFAA231</ArticleId><ArticleId IdType="pmc">PMC7665651</ArticleId><ArticleId IdType="pubmed">33022712</ArticleId></ArticleIdList></Reference><Reference><Citation>Farkash EA, Wilson AM, Jentzen JM. Ultrastructural evidence for direct renal infection with SARS-coV-2. J Am Soc Nephrol. (2020) 31:1683&#x2013;7. doi:&#xa0;10.1681/ASN.2020040432</Citation><ArticleIdList><ArticleId IdType="doi">10.1681/ASN.2020040432</ArticleId><ArticleId IdType="pmc">PMC7460898</ArticleId><ArticleId IdType="pubmed">32371536</ArticleId></ArticleIdList></Reference><Reference><Citation>Chueh TI, Zheng CM, Hou YC, Lu KC. Novel evidence of acute kidney injury in COVID-19. J Clin Med. (2020) 9:1&#x2013;14. doi:&#xa0;10.3390/JCM9113547</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/JCM9113547</ArticleId><ArticleId IdType="pmc">PMC7692179</ArticleId><ArticleId IdType="pubmed">33153216</ArticleId></ArticleIdList></Reference><Reference><Citation>Ahmadian E, Khatibi SMH, Soofiyani SR, Abediazar S, Shoja MM, Ardalan M, et al. . Covid-19 and kidney injury: Pathophysiology and molecular mechanisms. Rev Med Virol. (2021) 31:e2176. doi:&#xa0;10.1002/rmv.2176</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/rmv.2176</ArticleId><ArticleId IdType="pmc">PMC7646060</ArticleId><ArticleId IdType="pubmed">33022818</ArticleId></ArticleIdList></Reference><Reference><Citation>Donoghue M, Hsieh F, Baronas E, Godbout K, Gosselin M, Stagliano N, et al. . A novel angiotensin-converting enzyme&#x2013;related carboxypeptidase (ACE2) converts angiotensin I to angiotensin 1-9. Circ Res. (2000) 87:e1&#x2013;e9. doi:&#xa0;10.1161/01.RES.87.5.e1</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/01.RES.87.5.e1</ArticleId><ArticleId IdType="pubmed">10969042</ArticleId></ArticleIdList></Reference><Reference><Citation>Lores E, Wysocki J, Batlle D. ACE2, the kidney and the emergence of COVID-19 two decades after ACE2 discovery. Clin Sci. (2020) 134:2791&#x2013;805. doi:&#xa0;10.1042/CS20200484</Citation><ArticleIdList><ArticleId IdType="doi">10.1042/CS20200484</ArticleId><ArticleId IdType="pubmed">33135725</ArticleId></ArticleIdList></Reference><Reference><Citation>Crook H, Raza S, Nowell J, Young M, Edison P. Long covid&#x2014;mechanisms, risk factors, and management. BMJ. (2021) 374:n1648. doi:&#xa0;10.1136/bmj.n1648</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.n1648</ArticleId><ArticleId IdType="pubmed">34312178</ArticleId></ArticleIdList></Reference><Reference><Citation>Danladi J, Sabir H. Innate immunity, inflammation activation and heat-shock protein in COVID-19 pathogenesis. J Neuroimmunol. (2021) 358:577632. doi:&#xa0;10.1016/j.jneuroim.2021.577632</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jneuroim.2021.577632</ArticleId><ArticleId IdType="pmc">PMC8196476</ArticleId><ArticleId IdType="pubmed">34186336</ArticleId></ArticleIdList></Reference><Reference><Citation>Gao Y, Ding M, Dong X, Zhang J, Azkur AK, Azkur D, et al. . Risk factors for severe and critically ill COVID-19 patients: A review. Allergy. (2021) 76:428&#x2013;55. doi:&#xa0;10.1111/all.14657</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/all.14657</ArticleId><ArticleId IdType="pubmed">33185910</ArticleId></ArticleIdList></Reference><Reference><Citation>Peluso MJ, Deveau TM, Munter SE, Ryder D, Buck A, Beck-Engeser G, et al. . Chronic viral coinfections differentially affect the likelihood of developing long COVID. J Clin Invest. (2023) 133:e163669. doi:&#xa0;10.1172/JCI163669</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/JCI163669</ArticleId><ArticleId IdType="pmc">PMC9888380</ArticleId><ArticleId IdType="pubmed">36454631</ArticleId></ArticleIdList></Reference><Reference><Citation>Lan K, Luo MH. Herpesviruses: epidemiology, pathogenesis, and interventions. Virol Sin. (2017) 32:347. doi:&#xa0;10.1007/S12250-017-4108-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/S12250-017-4108-2</ArticleId><ArticleId IdType="pmc">PMC6598912</ArticleId><ArticleId IdType="pubmed">29116595</ArticleId></ArticleIdList></Reference><Reference><Citation>Mitchell BM, Bloom DC, Cohrs RJ, Gilden DH, Kennedy PGE. Herpes simplex virus-1 and varicella-zoster virus latency in ganglia. J Neurovirol. (2003) 9:194&#x2013;204. doi:&#xa0;10.1080/13550280390194000</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/13550280390194000</ArticleId><ArticleId IdType="pubmed">12707850</ArticleId></ArticleIdList></Reference><Reference><Citation>Katz J, Yue S, Xue W. Herpes simplex and herpes zoster viruses in COVID-19 patients. Ir J Med Sci. (2022) 191:1093. doi:&#xa0;10.1007/s11845-021-02714-z</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11845-021-02714-z</ArticleId><ArticleId IdType="pmc">PMC8272836</ArticleId><ArticleId IdType="pubmed">34247308</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu R, Zhou Y, Cai L, Wang L, Han J, Yang X, et al. . Co-reactivation of the human herpesvirus alpha subfamily (herpes simplex virus-1 and varicella zoster virus) in a critically ill patient with COVID-19. Br J Dermatol. (2020) 183:1145&#x2013;7. doi:&#xa0;10.1111/BJD.19484</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/BJD.19484</ArticleId><ArticleId IdType="pmc">PMC7436688</ArticleId><ArticleId IdType="pubmed">32790074</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim JYH, Ragusa M, Tortosa F, Torres A, Gresh L, M&#xe9;ndez-Rico JA, et al. . Viral reactivations and co-infections in COVID-19 patients: a systematic review. BMC Infect Dis. (2023) 23:1&#x2013;25. doi:&#xa0;10.1186/s12879-023-08117-y</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12879-023-08117-y</ArticleId><ArticleId IdType="pmc">PMC10131452</ArticleId><ArticleId IdType="pubmed">37101275</ArticleId></ArticleIdList></Reference><Reference><Citation>Simonnet A, Engelmann I, Moreau AS, Garcia B, Six S, El Kalioubie A, et al. . High incidence of Epstein-Barr virus, cytomegalovirus, and human-herpes virus-6 reactivations in critically ill patients with COVID-19. Infect Dis now. (2021) 51:296&#x2013;9. doi:&#xa0;10.1016/J.IDNOW.2021.01.005</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/J.IDNOW.2021.01.005</ArticleId><ArticleId IdType="pmc">PMC7816954</ArticleId><ArticleId IdType="pubmed">33495765</ArticleId></ArticleIdList></Reference><Reference><Citation>Pona A, Jiwani RA, Afriyie F, Labbe J, Cook PP, Mao Y. Herpes zoster as a potential complication of coronavirus disease 2019. Dermatol Ther. (2020) 33:e13930. doi:&#xa0;10.1111/DTH.13930</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/DTH.13930</ArticleId><ArticleId IdType="pmc">PMC7361152</ArticleId><ArticleId IdType="pubmed">32602610</ArticleId></ArticleIdList></Reference><Reference><Citation>Busani S, Bedini A, Biagioni E, Serio L, Tonelli R, Meschiari M, et al. . Two fatal cases of acute liver failure due to HSV-1 infection in COVID-19 patients following immunomodulatory therapies. Clin Infect Dis. (2021) 73:E252&#x2013;5. doi:&#xa0;10.1093/CID/CIAA1246</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/CID/CIAA1246</ArticleId><ArticleId IdType="pmc">PMC7499514</ArticleId><ArticleId IdType="pubmed">32840571</ArticleId></ArticleIdList></Reference><Reference><Citation>Perera MR, Greenwood EJD, Crozier TWM, Elder EG, Schmitt J, Crump CM, et al. . Human cytomegalovirus infection of epithelial cells increases SARS-coV-2 superinfection by upregulating the ACE2 receptor. J Infect Dis. (2023) 227:543&#x2013;53. doi:&#xa0;10.1093/INFDIS/JIAC452</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/INFDIS/JIAC452</ArticleId><ArticleId IdType="pmc">PMC9927080</ArticleId><ArticleId IdType="pubmed">36408607</ArticleId></ArticleIdList></Reference><Reference><Citation>Vojdani A, Vojdani E, Saidara E, Maes M. Persistent SARS-coV-2 infection, EBV, HHV-6 and other factors may contribute to inflammation and autoimmunity in long COVID. Viruses. (2023) 15:400. doi:&#xa0;10.3390/V15020400</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/V15020400</ArticleId><ArticleId IdType="pmc">PMC9967513</ArticleId><ArticleId IdType="pubmed">36851614</ArticleId></ArticleIdList></Reference><Reference><Citation>Ahamed J, Laurence J. Long COVID endotheliopathy: hypothesized mechanisms and potential therapeutic approaches. J Clin Invest. (2022) 132. doi:&#xa0;10.1172/JCI161167</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/JCI161167</ArticleId><ArticleId IdType="pmc">PMC9337829</ArticleId><ArticleId IdType="pubmed">35912863</ArticleId></ArticleIdList></Reference><Reference><Citation>Jafarzadeh A, Gosain R, Mortazavi SMJ, Nemati M, Jafarzadeh S, Ghaderi A. SARS-coV-2 infection: A possible risk factor for incidence and recurrence of cancers. Int J Hematol Stem Cell Res. (2022) 16:117&#x2013;27. doi:&#xa0;10.18502/IJHOSCR.V16I2.9205</Citation><ArticleIdList><ArticleId IdType="doi">10.18502/IJHOSCR.V16I2.9205</ArticleId><ArticleId IdType="pmc">PMC9547773</ArticleId><ArticleId IdType="pubmed">36304732</ArticleId></ArticleIdList></Reference><Reference><Citation>Komaroff AL, Lipkin WI. ME/CFS and Long COVID share similar symptoms and biological abnormalities: road map to the literature. Front Med. (2023) 10:1187163. doi:&#xa0;10.3389/FMED.2023.1187163</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/FMED.2023.1187163</ArticleId><ArticleId IdType="pmc">PMC10278546</ArticleId><ArticleId IdType="pubmed">37342500</ArticleId></ArticleIdList></Reference><Reference><Citation>Lam MHB, Wing YK, Yu MWM, Leung CM, Ma RCW, Kong APS, et al. . Mental morbidities and chronic fatigue in severe acute respiratory syndrome survivors: long-term follow-up. Arch Intern Med. (2009) 169:2142&#x2013;7. doi:&#xa0;10.1001/ARCHINTERNMED.2009.384</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/ARCHINTERNMED.2009.384</ArticleId><ArticleId IdType="pubmed">20008700</ArticleId></ArticleIdList></Reference><Reference><Citation>Shikova E, Reshkova V, Kumanova &#x410;, Raleva S, Alexandrova D, Capo N, et al. . Cytomegalovirus, Epstein-Barr virus, and human herpesvirus-6 infections in patients with myalgic &#x435;ncephalomyelitis/chronic fatigue syndrome. J Med Virol. (2020) 92:3682&#x2013;8. doi:&#xa0;10.1002/JMV.25744</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/JMV.25744</ArticleId><ArticleId IdType="pmc">PMC7687071</ArticleId><ArticleId IdType="pubmed">32129496</ArticleId></ArticleIdList></Reference><Reference><Citation>Peluso MJ, Deveau T-M, Munter SE, Ryder D, Buck A, Beck-Engeser G, et al. . Impact of pre-existing chronic viral infection and reactivation on the development of long COVID. medRxiv. (2022). doi:&#xa0;10.1101/2022.06.21.22276660</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2022.06.21.22276660</ArticleId></ArticleIdList></Reference><Reference><Citation>Gold JE, Okyay RA, Licht WE, Hurley DJ. Investigation of long COVID prevalence and its relationship to epstein-barr virus reactivation. Pathog (Basel Switzerland). (2021) 10:E1&#x2013;9. doi:&#xa0;10.3390/PATHOGENS10060763</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/PATHOGENS10060763</ArticleId><ArticleId IdType="pmc">PMC8233978</ArticleId><ArticleId IdType="pubmed">34204243</ArticleId></ArticleIdList></Reference><Reference><Citation>Zubchenko S, Kril I, Nadizhko O, Matsyura O, Chopyak V. Herpesvirus infections and post-COVID-19 manifestations: a pilot observational study. Rheumatol Int. (2022) 42:1523&#x2013;30. doi:&#xa0;10.1007/S00296-022-05146-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/S00296-022-05146-9</ArticleId><ArticleId IdType="pmc">PMC9159383</ArticleId><ArticleId IdType="pubmed">35650445</ArticleId></ArticleIdList></Reference><Reference><Citation>Leonso AA, Brown K, Prol R, Rawat S, Khunger A, Bromberg R. A rare case of latent tuberculosis reactivation secondary to a COVID-19 infection. Infect Dis Rep. (2022) 14:446. doi:&#xa0;10.3390/IDR14030048</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/IDR14030048</ArticleId><ArticleId IdType="pmc">PMC9222568</ArticleId><ArticleId IdType="pubmed">35735758</ArticleId></ArticleIdList></Reference><Reference><Citation>Tang W, Leonhardt L, Pervez A, Sarvepalli S. A case of pleural tuberculosis vs latent tuberculosis reactivation as a result of COVID-19 infection and treatment. J Community Hosp Intern Med Perspect. (2022) 12:90&#x2013;4. doi:&#xa0;10.55729/2000-9666.1078</Citation><ArticleIdList><ArticleId IdType="doi">10.55729/2000-9666.1078</ArticleId><ArticleId IdType="pmc">PMC9533800</ArticleId><ArticleId IdType="pubmed">36262898</ArticleId></ArticleIdList></Reference><Reference><Citation>Friedman A, Degeorge KC. Reactivation of latent tuberculosis in a COVID-19 patient on corticosteroid treatment. BMJ Case Rep. (2022) 15:e247562. doi:&#xa0;10.1136/BCR-2021-247562</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/BCR-2021-247562</ArticleId><ArticleId IdType="pmc">PMC9096484</ArticleId><ArticleId IdType="pubmed">35545310</ArticleId></ArticleIdList></Reference><Reference><Citation>Bardhan M, Hasan MM, Ray I, Sarkar A, Chahal P, Rackimuthu S, et al. . Tuberculosis amidst COVID-19 pandemic in India: unspoken challenges and the way forward. Trop Med Health. (2021) 49:84. doi:&#xa0;10.1186/S41182-021-00377-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/S41182-021-00377-1</ArticleId><ArticleId IdType="pmc">PMC8528656</ArticleId><ArticleId IdType="pubmed">34674772</ArticleId></ArticleIdList></Reference><Reference><Citation>Alemu A, Bitew ZW, Seid G, Diriba G, Gashu E, Berhe N, et al. . Tuberculosis in individuals who recovered from COVID-19: A systematic review of case reports. PloS One. (2022) 17:e0277807. doi:&#xa0;10.1371/JOURNAL.PONE.0277807</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/JOURNAL.PONE.0277807</ArticleId><ArticleId IdType="pmc">PMC9704624</ArticleId><ArticleId IdType="pubmed">36441785</ArticleId></ArticleIdList></Reference><Reference><Citation>
WHO Global Tuberculosis Report 2022 . 1. COVID-19 and TB. WHO rep
 (2022). Available online at: https://www.who.int/teams/global-tuberculosis-programme/tb-reports/global-tuberculosis-report-2022/covid-19-and-tb (Accessed October 24, 2023).</Citation></Reference><Reference><Citation>Ramasamy S, Subbian S. Critical determinants of cytokine storm and type I interferon response in COVID-19 pathogenesis. Clin Microbiol Rev. (2021) 34:e00299&#x2013;20. doi:&#xa0;10.1128/CMR.00299-20</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/CMR.00299-20</ArticleId><ArticleId IdType="pmc">PMC8142516</ArticleId><ArticleId IdType="pubmed">33980688</ArticleId></ArticleIdList></Reference><Reference><Citation>Patterson BK, Guevara-Coto J, Yogendra R, Francisco EB, Long E, Pise A, et al. . Immune-based prediction of COVID-19 severity and chronicity decoded using machine learning. Front Immunol. (2021) 12:700782. doi:&#xa0;10.3389/fimmu.2021.700782</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2021.700782</ArticleId><ArticleId IdType="pmc">PMC8273732</ArticleId><ArticleId IdType="pubmed">34262570</ArticleId></ArticleIdList></Reference><Reference><Citation>Canedo-Marroqu&#xed;n G, Saavedra F, Andrade CA, Berrios RV, Rodr&#xed;guez-Guilarte L, Opazo MC, et al. . SARS-coV-2: immune response elicited by infection and development of vaccines and treatments. Front Immunol. (2020) 11:569760. doi:&#xa0;10.3389/fimmu.2020.569760</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2020.569760</ArticleId><ArticleId IdType="pmc">PMC7759609</ArticleId><ArticleId IdType="pubmed">33362758</ArticleId></ArticleIdList></Reference><Reference><Citation>Carvalho T, Krammer F, Iwasaki A. The first 12 months of COVID-19: a timeline of immunological insights. Nat Rev Immunol. (2021) 21:245&#x2013;56. doi:&#xa0;10.1038/s41577-021-00522-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41577-021-00522-1</ArticleId><ArticleId IdType="pmc">PMC7958099</ArticleId><ArticleId IdType="pubmed">33723416</ArticleId></ArticleIdList></Reference><Reference><Citation>Dotan A, Muller S, Kanduc D, David P, Halpert G, Shoenfeld Y. The SARS-CoV-2 as an instrumental trigger of autoimmunity. Autoimmun Rev. (2021) 20:102792. doi:&#xa0;10.1016/j.autrev.2021.102792</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.autrev.2021.102792</ArticleId><ArticleId IdType="pmc">PMC7892316</ArticleId><ArticleId IdType="pubmed">33610751</ArticleId></ArticleIdList></Reference><Reference><Citation>Jordan SC. Innate and adaptive immune responses to SARS-CoV-2 in humans: relevance to acquired immunity and vaccine responses. Clin Exp Immunol. (2021) 204:310&#x2013;20. doi:&#xa0;10.1111/cei.13582</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/cei.13582</ArticleId><ArticleId IdType="pmc">PMC8013613</ArticleId><ArticleId IdType="pubmed">33534923</ArticleId></ArticleIdList></Reference><Reference><Citation>S&#xe1;nchez-Zuno GA, Matuz-Flores MG, Gonz&#xe1;lez-Estevez G, Nicoletti F, Turrubiates-Hern&#xe1;ndez FJ, Mangano K, et al. . A review: Antibody-dependent enhancement in COVID-19: The not so friendly side of antibodies. Int J Immunopathol Pharmacol. (2021) 35:205873842110501. doi:&#xa0;10.1177/20587384211050199</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/20587384211050199</ArticleId><ArticleId IdType="pmc">PMC8512237</ArticleId><ArticleId IdType="pubmed">34632844</ArticleId></ArticleIdList></Reference><Reference><Citation>Sette A, Crotty S. Adaptive immunity to SARS-coV-2 and COVID-19. Cell. (2021) 184:861&#x2013;80. doi:&#xa0;10.1016/j.cell.2021.01.007</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2021.01.007</ArticleId><ArticleId IdType="pmc">PMC7803150</ArticleId><ArticleId IdType="pubmed">33497610</ArticleId></ArticleIdList></Reference><Reference><Citation>Hu B, Huang S, Yin L. The cytokine storm and COVID-19. J Med Virol. (2021) 93:250&#x2013;6. doi:&#xa0;10.1002/jmv.26232</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.26232</ArticleId><ArticleId IdType="pmc">PMC7361342</ArticleId><ArticleId IdType="pubmed">32592501</ArticleId></ArticleIdList></Reference><Reference><Citation>Ye Q, Wang B, Mao J. The pathogenesis and treatment of the `Cytokine Storm&#x2019; in COVID-19. J Infect. (2020) 80:607&#x2013;13. doi:&#xa0;10.1016/j.jinf.2020.03.037</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jinf.2020.03.037</ArticleId><ArticleId IdType="pmc">PMC7194613</ArticleId><ArticleId IdType="pubmed">32283152</ArticleId></ArticleIdList></Reference><Reference><Citation>Arish M, Qian W, Narasimhan H, Sun J. COVID-19 immunopathology: From acute diseases to chronic sequelae. J Med Virol. (2023) 95:e28122. doi:&#xa0;10.1002/JMV.28122</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/JMV.28122</ArticleId><ArticleId IdType="pmc">PMC9537925</ArticleId><ArticleId IdType="pubmed">36056655</ArticleId></ArticleIdList></Reference><Reference><Citation>Tana C, Cinetto F, Mantini C, Bernardinello N, Tana M, Ricci F, et al. . Sarcoidosis and COVID-19: at the cross-road between immunopathology and clinical manifestation. Biomedicines. (2022) 10:2525. doi:&#xa0;10.3390/BIOMEDICINES10102525</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/BIOMEDICINES10102525</ArticleId><ArticleId IdType="pmc">PMC9599235</ArticleId><ArticleId IdType="pubmed">36289785</ArticleId></ArticleIdList></Reference><Reference><Citation>Dorward DA, Russell CD, Um IH, Elshani M, Armstrong SD, Penrice-Randal R, et al. . Tissue-specific immunopathology in fatal COVID-19. Am J Respir Crit Care Med. (2021) 203:192&#x2013;201. doi:&#xa0;10.1164/rccm.202008-3265OC</Citation><ArticleIdList><ArticleId IdType="doi">10.1164/rccm.202008-3265OC</ArticleId><ArticleId IdType="pmc">PMC7874430</ArticleId><ArticleId IdType="pubmed">33217246</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen Y-M, Zheng Y, Yu Y, Wang Y, Huang Q, Qian F, et al. . Blood molecular markers associated with COVID-19 immunopathology and multi-organ damage. EMBO J. (2020) 39:e105896. doi:&#xa0;10.15252/EMBJ.2020105896</Citation><ArticleIdList><ArticleId IdType="doi">10.15252/EMBJ.2020105896</ArticleId><ArticleId IdType="pmc">PMC7737620</ArticleId><ArticleId IdType="pubmed">33140861</ArticleId></ArticleIdList></Reference><Reference><Citation>Gong F, Dai Y, Zheng T, Cheng L, Zhao D, Wang H, et al. . Peripheral CD4+ T cell subsets and antibody response in COVID-19 convalescent individuals. J Clin Invest. (2020) 130:6588&#x2013;99. doi:&#xa0;10.1172/JCI141054</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/JCI141054</ArticleId><ArticleId IdType="pmc">PMC7685722</ArticleId><ArticleId IdType="pubmed">32841212</ArticleId></ArticleIdList></Reference><Reference><Citation>Kared H, Redd AD, Bloch EM, Bonny TS, Sumatoh H, Kairi F, et al. . SARS-CoV-2&#x2013;specific CD8+ T cell responses in convalescent COVID-19 individuals. J Clin Invest. (2021) 131:e145476. doi:&#xa0;10.1172/JCI145476</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/JCI145476</ArticleId><ArticleId IdType="pmc">PMC7919723</ArticleId><ArticleId IdType="pubmed">33427749</ArticleId></ArticleIdList></Reference><Reference><Citation>Nguyen-Contant P, Embong AK, Kanagaiah P, Chaves FA, Yang H, Branche AR, et al. . S protein-reactive igG and memory B cell production after human SARS-coV-2 infection includes broad reactivity to the S2 subunit. MBio. (2020) 11:e01991&#x2013;20. doi:&#xa0;10.1128/mBio.01991-20</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/mBio.01991-20</ArticleId><ArticleId IdType="pmc">PMC7520599</ArticleId><ArticleId IdType="pubmed">32978311</ArticleId></ArticleIdList></Reference><Reference><Citation>Ni L, Ye F, Cheng M-L, Feng Y, Deng Y-Q, Zhao H, et al. . Detection of SARS-coV-2-specific humoral and cellular immunity in COVID-19 convalescent individuals. Immunity. (2020) 52:971&#x2013;977.e3. doi:&#xa0;10.1016/j.immuni.2020.04.023</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.immuni.2020.04.023</ArticleId><ArticleId IdType="pmc">PMC7196424</ArticleId><ArticleId IdType="pubmed">32413330</ArticleId></ArticleIdList></Reference><Reference><Citation>Toor SM, Saleh R, Nair VS, Taha RZ, Elkord E. T-cell responses and therapies against SARS-CoV-2 infection. Immunology. (2021) 162:30&#x2013;43. doi:&#xa0;10.1111/imm.13262</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/imm.13262</ArticleId><ArticleId IdType="pmc">PMC7730020</ArticleId><ArticleId IdType="pubmed">32935333</ArticleId></ArticleIdList></Reference><Reference><Citation>Ryan FJ, Hope CM, Masavuli MG, Lynn MA, Mekonnen ZA, Yeow AEL, et al. . Long-term perturbation of the peripheral immune system months after SARS-CoV-2 infection. BMC Med. (2022) 20:26. doi:&#xa0;10.1186/s12916-021-02228-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12916-021-02228-6</ArticleId><ArticleId IdType="pmc">PMC8758383</ArticleId><ArticleId IdType="pubmed">35027067</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang Z, Wang S, Goplen NP, Li C, Cheon IS, Dai Q, et al. . PD-1 hi CD8+ resident memory T cells balance immunity and fibrotic sequelae. Sci Immunol. (2019) 4:eaaw1217. doi:&#xa0;10.1126/sciimmunol.aaw1217</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/sciimmunol.aaw1217</ArticleId><ArticleId IdType="pmc">PMC7458867</ArticleId><ArticleId IdType="pubmed">31201259</ArticleId></ArticleIdList></Reference><Reference><Citation>Goplen NP, Wu Y, Son YM, Li C, Wang Z, Cheon IS, et al. . Tissue-resident CD8+ T cells drive age-associated chronic lung sequelae after viral pneumonia. Sci Immunol. (2020) 5:eabc4557. doi:&#xa0;10.1126/sciimmunol.abc4557</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/sciimmunol.abc4557</ArticleId><ArticleId IdType="pmc">PMC7970412</ArticleId><ArticleId IdType="pubmed">33158975</ArticleId></ArticleIdList></Reference><Reference><Citation>Ganji A, Farahani I, Khansarinejad B, Ghazavi A, Mosayebi G. Increased expression of CD8 marker on T-cells in COVID-19 patients. Blood Cells Mol Dis. (2020) 83:102437. doi:&#xa0;10.1016/j.bcmd.2020.102437</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bcmd.2020.102437</ArticleId><ArticleId IdType="pmc">PMC7194879</ArticleId><ArticleId IdType="pubmed">32325421</ArticleId></ArticleIdList></Reference><Reference><Citation>Al-Attiyah R, Safar HA, Botras L, Botras M, Al-Kandari F, Chehadeh W, et al. . Immune cells profiles in the peripheral blood of patients with moderate to severe COVID-19 and healthy subjects with and without vaccination with the pfizer-bioNTech mRNA vaccine. Front Immunol. (2022) 13:851765. doi:&#xa0;10.3389/fimmu.2022.851765</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2022.851765</ArticleId><ArticleId IdType="pmc">PMC9309529</ArticleId><ArticleId IdType="pubmed">35898494</ArticleId></ArticleIdList></Reference><Reference><Citation>Patterson BK, Seethamraju H, Dhody K, Corley MJ, Kazempour K, Lalezari J, et al. . CCR5 inhibition in critical COVID-19 patients decreases inflammatory cytokines, increases CD8 T-cells, and decreases SARS-CoV2 RNA in plasma by day 14. Int J Infect Dis. (2021) 103:25&#x2013;32. doi:&#xa0;10.1016/j.ijid.2020.10.101</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijid.2020.10.101</ArticleId><ArticleId IdType="pmc">PMC7654230</ArticleId><ArticleId IdType="pubmed">33186704</ArticleId></ArticleIdList></Reference><Reference><Citation>Patterson BK, Francisco EB, Yogendra R, Long E, Pise A, Rodrigues H, et al. . Persistence of SARS coV-2 S1 protein in CD16+ Monocytes in post-acute sequelae of COVID-19 (PASC) up to 15 months post-infection. Front Immunol. (2022) 12:746021. doi:&#xa0;10.3389/fimmu.2021.746021</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2021.746021</ArticleId><ArticleId IdType="pmc">PMC8784688</ArticleId><ArticleId IdType="pubmed">35082777</ArticleId></ArticleIdList></Reference><Reference><Citation>Santopaolo M, Gregorova M, Hamilton F, Arnold D, Long A, Lacey A, et al. . Prolonged T-cell activation and long COVID symptoms independently associate with severe COVID-19 at 3 months. Elife. (2023) 12:e85009. doi:&#xa0;10.7554/ELIFE.85009</Citation><ArticleIdList><ArticleId IdType="doi">10.7554/ELIFE.85009</ArticleId><ArticleId IdType="pmc">PMC10319436</ArticleId><ArticleId IdType="pubmed">37310006</ArticleId></ArticleIdList></Reference><Reference><Citation>Altmann DM, Reynolds CJ, Joy G, Otter AD, Gibbons JM, Pade C, et al. . Persistent symptoms after COVID-19 are not associated with differential SARS-CoV-2 antibody or T cell immunity. Nat Commun. (2023) 14:1&#x2013;9. doi:&#xa0;10.1038/s41467-023-40460-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-023-40460-1</ArticleId><ArticleId IdType="pmc">PMC10447583</ArticleId><ArticleId IdType="pubmed">37612310</ArticleId></ArticleIdList></Reference><Reference><Citation>Krishna BA, Lim EY, Mactavous L, Lyons PA, Doffinger R, Bradley JR, et al. . Evidence of previous SARS-CoV-2 infection in seronegative patients with long COVID. EBioMedicine. (2022) 81:104129. doi:&#xa0;10.1016/J.EBIOM.2022.104129</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/J.EBIOM.2022.104129</ArticleId><ArticleId IdType="pmc">PMC9235296</ArticleId><ArticleId IdType="pubmed">35772216</ArticleId></ArticleIdList></Reference><Reference><Citation>Seydoux E, Homad LJ, MacCamy AJ, Parks KR, Hurlburt NK, Jennewein MF, et al. . Analysis of a SARS-coV-2-infected individual reveals development of potent neutralizing antibodies with limited somatic mutation. Immunity. (2020) 53:98&#x2013;105.e5. doi:&#xa0;10.1016/j.immuni.2020.06.001</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.immuni.2020.06.001</ArticleId><ArticleId IdType="pmc">PMC7276322</ArticleId><ArticleId IdType="pubmed">32561270</ArticleId></ArticleIdList></Reference><Reference><Citation>Sedaghat Z, Karimi N. Guillain Barre syndrome associated with COVID-19 infection: A case report. J Clin Neurosci. (2020) 76:233&#x2013;5. doi:&#xa0;10.1016/j.jocn.2020.04.062</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jocn.2020.04.062</ArticleId><ArticleId IdType="pmc">PMC7158817</ArticleId><ArticleId IdType="pubmed">32312628</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu Z, Hu Y, Xu M, Chen Z, Yang W, Jiang Z, et al. . Safety, tolerability, and immunogenicity of an inactivated SARS-CoV-2 vaccine (CoronaVac) in healthy adults aged 60 years and older: a randomised, double-blind, placebo-controlled, phase 1/2 clinical trial. Lancet Infect Dis. (2021) 21:803&#x2013;12. doi:&#xa0;10.1016/S1473-3099(20)30987-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1473-3099(20)30987-7</ArticleId><ArticleId IdType="pmc">PMC7906628</ArticleId><ArticleId IdType="pubmed">33548194</ArticleId></ArticleIdList></Reference><Reference><Citation>Alencar CH, de G&#xf3;es Cavalcanti LP, de Almeida MM, Barbosa PPL, de Sousa Cavalcante KK, de Melo DN, et al. . High effectiveness of SARS-coV-2 vaccines in reducing COVID-19-related deaths in over 75-year-olds, cear&#xe1; State, Brazil. Trop Med Infect Dis. (2021) 6:129. doi:&#xa0;10.3390/tropicalmed6030129</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/tropicalmed6030129</ArticleId><ArticleId IdType="pmc">PMC8293450</ArticleId><ArticleId IdType="pubmed">34287384</ArticleId></ArticleIdList></Reference><Reference><Citation>Collier DA, Ferreira IATM, Kotagiri P, Datir RP, Lim EY, Touizer E, et al. . Age-related immune response heterogeneity to SARS-CoV-2 vaccine BNT162b2. Nature. (2021) 596:417&#x2013;22. doi:&#xa0;10.1038/s41586-021-03739-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-021-03739-1</ArticleId><ArticleId IdType="pmc">PMC8373615</ArticleId><ArticleId IdType="pubmed">34192737</ArticleId></ArticleIdList></Reference><Reference><Citation>Farias JP, de Souza da Silva P, Foga&#xe7;a MMC, Santana IVR, Luiz WB, Birbrair A, et al. . The COVID-19 humoral immunological status induced by coronaVac and astraZeneca vaccines significantly benefits from a booster shot with the pfizer vaccine. J Virol. (2022) 96(8):e0017722. doi:&#xa0;10.1128/jvi.00177-22</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/jvi.00177-22</ArticleId><ArticleId IdType="pmc">PMC9044956</ArticleId><ArticleId IdType="pubmed">35389263</ArticleId></ArticleIdList></Reference><Reference><Citation>Kang M, Yi Y, Li Y, Sun L, Deng A, Hu T, et al. . Effectiveness of inactivated COVID-19 vaccines against COVID-19 pneumonia and severe illness caused by the B.1.617.2 (Delta) variant: evidence from an outbreak in guangdong, China. SSRN Electron J. (2021) 175(11):533&#x2013;40. doi:&#xa0;10.2139/ssrn.3895639</Citation><ArticleIdList><ArticleId IdType="doi">10.2139/ssrn.3895639</ArticleId><ArticleId IdType="pmc">PMC8819853</ArticleId><ArticleId IdType="pubmed">35099990</ArticleId></ArticleIdList></Reference><Reference><Citation>Bernal JL, Andrews N, Gower C, Gallagher E, Simmons R, Thelwall S, et al. . Effectiveness of covid-19 vaccines against the B.1.617.2 (Delta) variant. N Engl J Med. (2021) 385:585&#x2013;94. doi:&#xa0;10.1056/NEJMoa2108891</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa2108891</ArticleId><ArticleId IdType="pmc">PMC8314739</ArticleId><ArticleId IdType="pubmed">34289274</ArticleId></ArticleIdList></Reference><Reference><Citation>Saur&#xe9; D, O&#x2019;Ryan M, Torres JP, Zuniga M, Santelices E, Basso LJ. Dynamic IgG seropositivity after rollout of CoronaVac and BNT162b2 COVID-19 vaccines in Chile: a sentinel surveillance study. Lancet Infect Dis. (2022) 22:56&#x2013;63. doi:&#xa0;10.1016/S1473-3099(21)00479-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1473-3099(21)00479-5</ArticleId><ArticleId IdType="pmc">PMC8428469</ArticleId><ArticleId IdType="pubmed">34509185</ArticleId></ArticleIdList></Reference><Reference><Citation>Woodruff MC, Bonham KS, Anam FA, Walker TA, Faliti CE, Ishii Y, et al. . Chronic inflammation, neutrophil activity, and autoreactivity splits long COVID. Nat Commun. (2023) 14:4201. doi:&#xa0;10.1038/S41467-023-40012-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/S41467-023-40012-7</ArticleId><ArticleId IdType="pmc">PMC10349085</ArticleId><ArticleId IdType="pubmed">37452024</ArticleId></ArticleIdList></Reference><Reference><Citation>Woodruff MC, Ramonell RP, Nguyen DC, Cashman KS, Saini AS, Haddad NS, et al. . Extrafollicular B cell responses correlate with neutralizing antibodies and morbidity in COVID-19. Nat Immunol. (2020) 21:1506&#x2013;16. doi:&#xa0;10.1038/s41590-020-00814-z</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41590-020-00814-z</ArticleId><ArticleId IdType="pmc">PMC7739702</ArticleId><ArticleId IdType="pubmed">33028979</ArticleId></ArticleIdList></Reference><Reference><Citation>Voss LF, Howarth AJ, Wittenborn TR, Hummelgaard S, Juul-Madsen K, Kastberg KS, et al. . The extrafollicular response is sufficient to drive initiation of autoimmunity and early disease hallmarks of lupus. Front Immunol. (2022) 13:1021370. doi:&#xa0;10.3389/FIMMU.2022.1021370</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/FIMMU.2022.1021370</ArticleId><ArticleId IdType="pmc">PMC9795406</ArticleId><ArticleId IdType="pubmed">36591222</ArticleId></ArticleIdList></Reference><Reference><Citation>Bastard P, Rosen LB, Zhang Q, Michailidis E, Hoffmann H-H, Zhang Y, et al. . Autoantibodies against type I IFNs in patients with life-threatening COVID-19. Science (80-). (2020) 370:eabd4585. doi:&#xa0;10.1126/science.abd4585</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.abd4585</ArticleId><ArticleId IdType="pmc">PMC7857397</ArticleId><ArticleId IdType="pubmed">32972996</ArticleId></ArticleIdList></Reference><Reference><Citation>Troya J, Bastard P, Planas-Serra L, Ryan P, Ruiz M, de Carranza M, et al. . Neutralizing autoantibodies to type I IFNs in &gt; 10% of patients with severe COVID-19 pneumonia hospitalized in madrid, Spain. J Clin Immunol. (2021) 41:914&#x2013;22. doi:&#xa0;10.1007/s10875-021-01036-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10875-021-01036-0</ArticleId><ArticleId IdType="pmc">PMC8043439</ArticleId><ArticleId IdType="pubmed">33851338</ArticleId></ArticleIdList></Reference><Reference><Citation>Thurner L, Fadle N, Regitz E, Preuss K-D, Neumann F, Cetin O, et al. . Autoantibodies against SUMO1-DHX35 in long-COVID. J Transl Autoimmun. (2022) 5:100171. doi:&#xa0;10.1016/j.jtauto.2022.100171</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jtauto.2022.100171</ArticleId><ArticleId IdType="pmc">PMC9675633</ArticleId><ArticleId IdType="pubmed">36425003</ArticleId></ArticleIdList></Reference><Reference><Citation>Wallukat G, Hohberger B, Wenzel K, F&#xfc;rst J, Schulze-Rothe S, Wallukat A, et al. . Functional autoantibodies against G-protein coupled receptors in patients with persistent Long-COVID-19 symptoms. J Transl Autoimmun. (2021) 4:100100. doi:&#xa0;10.1016/J.JTAUTO.2021.100100</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/J.JTAUTO.2021.100100</ArticleId><ArticleId IdType="pmc">PMC8049853</ArticleId><ArticleId IdType="pubmed">33880442</ArticleId></ArticleIdList></Reference><Reference><Citation>Achleitner M, Steenblock C, D&#xe4;nhardt J, Jarzebska N, Kardashi R, Kanczkowski W, et al. . Clinical improvement of Long-COVID is associated with reduction in autoantibodies, lipids, and inflammation following therapeutic apheresis. Mol Psychiatry. (2023) 28(7):1&#x2013;6. doi:&#xa0;10.1038/s41380-023-02084-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41380-023-02084-1</ArticleId><ArticleId IdType="pmc">PMC10152027</ArticleId><ArticleId IdType="pubmed">37131073</ArticleId></ArticleIdList></Reference><Reference><Citation>Seibert FS, Stervbo U, Wiemers L, Skrzypczyk S, Hogeweg M, Bertram S, et al. . Severity of neurological Long-COVID symptoms correlates with increased level of autoantibodies targeting vasoregulatory and autonomic nervous system receptors. Autoimmun Rev. (2023) 22:103445. doi:&#xa0;10.1016/J.AUTREV.2023.103445</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/J.AUTREV.2023.103445</ArticleId><ArticleId IdType="pubmed">37689093</ArticleId></ArticleIdList></Reference><Reference><Citation>Zuo J, Dowell AC, Pearce H, Verma K, Long HM, Begum J, et al. . Robust SARS-CoV-2-specific T cell immunity is maintained at 6 months following primary infection. Nat Immunol. (2021) 22:620&#x2013;6. doi:&#xa0;10.1038/s41590-021-00902-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41590-021-00902-8</ArticleId><ArticleId IdType="pmc">PMC7610739</ArticleId><ArticleId IdType="pubmed">33674800</ArticleId></ArticleIdList></Reference><Reference><Citation>Magadum A, Kishore R. Cardiovascular manifestations of COVID-19 infection. Cells. (2020) 9:2508. doi:&#xa0;10.3390/cells9112508</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/cells9112508</ArticleId><ArticleId IdType="pmc">PMC7699571</ArticleId><ArticleId IdType="pubmed">33228225</ArticleId></ArticleIdList></Reference><Reference><Citation>Blanco J-R, Cobos-Ceballos M-J, Navarro F, Sanjoaquin I, de las Revillas FA, Bernal E, et al. . Pulmonary long-term consequences of COVID-19 infections after hospital discharge. Clin Microbiol Infect. (2021) 27:892&#x2013;6. doi:&#xa0;10.1016/j.cmi.2021.02.019</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cmi.2021.02.019</ArticleId><ArticleId IdType="pmc">PMC7920814</ArticleId><ArticleId IdType="pubmed">33662544</ArticleId></ArticleIdList></Reference><Reference><Citation>Ellul M, Varatharaj A, Nicholson TR, Pollak TA, Thomas N, Easton A, et al. . Defining causality in COVID-19 and neurological disorders. J Neurol Neurosurg Psychiatry. (2020) 91:811&#x2013;2. doi:&#xa0;10.1136/jnnp-2020-323667</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp-2020-323667</ArticleId><ArticleId IdType="pmc">PMC7299654</ArticleId><ArticleId IdType="pubmed">32503883</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang P-CC, Jafri MS. Ca2+ signaling in T lymphocytes: the interplay of the endoplasmic reticulum, mitochondria, membrane potential, and CRAC channels on transcription factor activation. Heliyon. (2020) 6:e03526. doi:&#xa0;10.1016/j.heliyon.2020.e03526</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.heliyon.2020.e03526</ArticleId><ArticleId IdType="pmc">PMC7063158</ArticleId><ArticleId IdType="pubmed">32181396</ArticleId></ArticleIdList></Reference><Reference><Citation>Al-Kayali RS, Kashkash MF, Alhussein Alhajji AH, Khouri A. Activation of tuberculosis in recovered COVID-19 patients: a case report. Ann Med Surg. (2023) 85:280&#x2013;3. doi:&#xa0;10.1097/MS9.0000000000000188</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/MS9.0000000000000188</ArticleId><ArticleId IdType="pmc">PMC9949802</ArticleId><ArticleId IdType="pubmed">36845786</ArticleId></ArticleIdList></Reference><Reference><Citation>Afrin LB, Weinstock LB, Molderings GJ. Covid-19 hyperinflammation and post-Covid-19 illness may be rooted in mast cell activation syndrome. Int J Infect Dis. (2020) 100:327&#x2013;32. doi:&#xa0;10.1016/j.ijid.2020.09.016</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijid.2020.09.016</ArticleId><ArticleId IdType="pmc">PMC7529115</ArticleId><ArticleId IdType="pubmed">32920235</ArticleId></ArticleIdList></Reference><Reference><Citation>Doykov I, H&#xe4;llqvist J, Gilmour KC, Grandjean L, Mills K, Heywood WE. &#x2018;The long tail of Covid-19&#x2019; - The detection of a prolonged inflammatory response after a SARS-CoV-2 infection in asymptomatic and mildly affected patients. F1000Research. (2021) 9:1349. doi:&#xa0;10.12688/f1000research.27287.2</Citation><ArticleIdList><ArticleId IdType="doi">10.12688/f1000research.27287.2</ArticleId><ArticleId IdType="pmc">PMC7745182</ArticleId><ArticleId IdType="pubmed">33391730</ArticleId></ArticleIdList></Reference><Reference><Citation>Fadini GP, Morieri ML, Longato E, Avogaro A. Prevalence and impact of diabetes among people infected with SARS-CoV-2. J Endocrinol Invest. (2020) 43:867&#x2013;9. doi:&#xa0;10.1007/s40618-020-01236-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s40618-020-01236-2</ArticleId><ArticleId IdType="pmc">PMC7103097</ArticleId><ArticleId IdType="pubmed">32222956</ArticleId></ArticleIdList></Reference><Reference><Citation>Sardu C, D&#x2019;Onofrio N, Balestrieri ML, Barbieri M, Rizzo MR, Messina V, et al. . Outcomes in patients with hyperglycemia affected by COVID-19: can we do more on glycemic control? Diabetes Care. (2020) 43:1408&#x2013;15. doi:&#xa0;10.2337/dc20-0723</Citation><ArticleIdList><ArticleId IdType="doi">10.2337/dc20-0723</ArticleId><ArticleId IdType="pmc">PMC7305003</ArticleId><ArticleId IdType="pubmed">32430456</ArticleId></ArticleIdList></Reference><Reference><Citation>Reese JT, Blau H, Casiraghi E, Bergquist T, Loomba JJ, Callahan TJ, et al. . Generalisable long COVID subtypes: findings from the NIH N3C and RECOVER programmes. EBioMedicine. (2023) 87:104413. doi:&#xa0;10.1016/J.EBIOM.2022.104413</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/J.EBIOM.2022.104413</ArticleId><ArticleId IdType="pmc">PMC9769411</ArticleId><ArticleId IdType="pubmed">36563487</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>